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ABSTRACT
Electrochemically activated persulfate (EAP) is a potential point source treatment for wastewater
effluents containing high pharmaceutical content. This dissertation explores the fundamental
mechanisms of EAP to better understand this technology for practical application. Ciprofloxacin,
a fluoroquinolone antibiotic, was chosen as the model compound to assess parameters of EAP.
Ciprofloxacin was selected for its high environmental risk factor and prevalence in hospital
wastewater, a potential application for EAP.

During the evaluation of EAP as a point source

treatment, degradation kinetics and pathways of ciprofloxacin were elucidated.
In the first stage of this study, persulfate activation by solid iron with and without applied
current was characterized and applied to the degradation of ciprofloxacin. It was found that
persulfate activation increased with iron surface area and increased to a plateau with increasing
current. Ciprofloxacin degraded via first-order kinetics; however, applied current did not affect
ciprofloxacin removal.
In the second part of this study, electrochemical persulfate activation without iron, using
boron-doped diamond (BDD) anodes and graphite or platinum cathodes, was examined. Sulfate
radical formation at a BDD anode and persulfate activation at a graphite cathode were elucidated
using different electrolytes and electrochemical set-ups. In this system, ciprofloxacin degraded via
first order-kinetics, with persulfate electrolyte enhancing ciprofloxacin removal over sulfate or
nitrate.
In the final phase of this study, parameters such as reactor configuration, electrode surface
area, persulfate concentrations and the presence of a complex matrix were examined to determine
their impact on contaminant removal. Due to mass transfer limitations and relative cathode sizes,
v

a flow-through reactor was least benefited by persulfate addition while a rotating-disk electrode
reactor showed enhanced ciprofloxacin removal with persulfate electrolyte. Ciprofloxacin removal
from synthetic hospital effluent using electrochemically activated persulfate was found to be less
than that in pure electrolyte but still followed a first-order mechanism. Considerable total organic
carbon removal of ciprofloxacin and other organic components of the effluent was achieved.
Similar degradation was achieved with persulfate and sulfate electrolyte in the effluent. Chlorate,
chlorite and perchlorate were formed in significant amounts during the electrochemical process,
with formation independent of the presence of persulfate.
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CHAPTER ONE: INTRODUCTION
Pharmaceuticals, including antibiotics, are classified as contaminants of emerging concern in
ground and surface waters in the United States and worldwide1, 2. In many aquatic ecosystems,
individual antibiotics are detected in the ng L-1 to low µg L-1 range3-6. As the antibiotic
concentration increases, adverse ecological effects may include reproductive interferences in
crustaceans7-9, disruption of the nitrification process in nitrifying bacteria10, toxicity to algae11 and
growth of antibiotic resistant bacteria12.

Potential for ecological impacts arising from the

cumulative or synergistic effect of multiple antibiotics in a single aqueous system may also exist,
exacerbating the impacts of single contaminant behavior6, 7, 13, 14.
Effluents from wastewater treatment plants (WWTPs) are a primary source of
pharmaceutical introduction to surface water, and concern exists around localized “hotspots”
where concentrations of antibiotics are relatively high1, 2, 15-17. Pharmaceuticals most often enter
the waste stream from un-metabolized fractions found in human waste18,

19

.

Traditional

wastewater treatment processes are ineffective in completely degrading pharmaceuticals, so a
portion passes through the WWTP into surface water unchanged20, 21. Hospital wastewaters have
been identified as a significant source of pharmaceuticals entering WWTPs2, 22, 23. Studies suggest
a <10% to 50% hospital input to individual pharmaceuticals entering WWTPs, depending on the
specific substance, and a hospital contribution from 10-94% to the amount of some
pharmaceuticals found in the environment24, 25. Discharge from WWTPs servicing pharmaceutical
manufacturers has also been shown to contain elevated pharmaceutical levels26.
The fluoroquinolone antibiotic ciprofloxacin has been identified as an environmentally
high-risk pharmaceutical in multiple studies, making it a prioritization for environmental
1

monitoring and remediation1,

25, 27-32

.

Hospital contribution to the environmental risk of

ciprofloxacin was elucidated by Helwig et. al (2016), Ory et. al (2016), and Santos et. al (2013)25,
28, 29

. Other sources of environmental ciprofloxacin include pharmaceutical manufacturer effluent

and agricultural run-off, which are often untreated31, 33.
The environmental hazards of ciprofloxacin include toxicity to algae and invertebrates,
interference with plant growth /reproduction and contribution to antibiotic-resistance bacteria1, 27,
28, 31

. Genotoxicity of hospital effluent has also been attributed to ciprofloxacin and other

fluoroquinolone antibiotics34. Ciprofloxacin has the potential to create toxic synergistic impacts
in the presence of other hazardous compounds28. Because of its high risk-factor and prevalence in
hospital wastewater, ciprofloxacin has been selected as the compound of interest for the current
series of studies.
Point source treatment of hospital effluent, where pharmaceutical concentrations are high,
offers an effective solution to mitigate antibiotic entry to surface water22,

28

.

Membrane

bioreactors, powdered activated carbon, ultraviolet light, and ozonation are the most commonly
examined processes for the treatment of hospital wastewater35. Advanced oxidation processes
(AOP) using ozone/hydrogen peroxide (O3/H2O2), ozone/ultraviolet light (O3/UV), Fenton’s,
sono-Fenton’s, and UV/O3/H2O2 have been studied for the destruction of ciprofloxacin,
metronidazole, levofloxacin and trimethoprim in hospital effluent and other systems36-39. Many of
these options have been investigated as pre-treatment steps, secondary stages or tertiary steps in
lab-scale, pilot-scale and full-scale processes24, 35, 40. As noted by Verlicchi et. al (2015), the ideal
treatment of hospital effluent takes into account a complex mixture of variables including hospital
size, effluent composition, removal efficiencies for target compounds, receiving WWTP processes
2

and economic factors35. Less selective treatment methods are warranted as antibiotics and other
pharmaceuticals exhibit varying properties. The availability of multiple treatment options enables
better selection of the best process for a specific treatment challenge.
Electrochemical advanced oxidation processes (EAOPs) are a candidate for removal of
fluoroquinolone antibiotics, pharmaceuticals and other targeted pollutants like x-ray contrast
media22, 41-45. EAOPs are described in Chapter 4.1 and offer the advantage of eliminating total
organic carbon (TOC), which may contain harmful transformation byproducts46, 47.
Activated persulfate is another AOP recognized as a method to degrade an assortment of
environmental contaminants, including many antibiotics that traditional wastewater treatment
processes do not remove48. A comprehensive review of activated persulfate processes to treat over
70 organic compounds is offered in Chapter 2.
Electrochemically activated persulfate (EAP), explained in Chapter 2.4.1, may offer the
advantages of both activated persulfate and EAOP for treatment of pharmaceuticals in hospital
effluent. The research described in Chapters 3, 4 and 5 focuses on application of EAP to
ciprofloxacin degradation. Throughout these studies, ciprofloxacin removal is analyzed in detail,
while ciprofloxacin is also used as a model compound to understand the fundamentals of EAP.
Chapter 3 explores EAP using an iron anode with and without applied current. Kinetics of
persulfate activation and ciprofloxacin removal based on iron surface area and varying applied
current are examined. Chapter 4 concentrates on EAP using a boron-doped diamond anode. Iron
introduction to the system is avoided. Chapter 4 offers significant insight into anodic and cathodic
processes involved in EAP. Kinetics of persulfate ciprofloxacin removal and persulfate activation
are analyzed. Chapter 5 expands the focus of Chapter 4 by exploring the effects of reactor
3

configurations, cathode sizes and persulfate concentrates on ciprofloxacin removal using EAP
without iron. Chapter 5 also evaluates ciprofloxacin removal from synthetic hospital effluent and
inorganic disinfection by-products formed during the EAP process.
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CHAPTER TWO: ACTIVATED PERSULFATE FOR ORGANIC DEGRADATION: A
REVIEW
This chapter is revised based on a paper published by Laura W. Matzek and Kimberly E. Carter,
as follows:
Matzek, L. W.; Carter, K. E., Activated persulfate for organic chemical degradation: A review.
Chemosphere 2016, 151, 178-188.
Excerpts are also included from a paper published by Laura W. Matzek and Kimberly E. Carter,
as follows:
Matzek, L. W.; Carter, K. E., Sustained persulfate activation using solid iron: Kinetics and
application to ciprofloxacin degradation. Chem Eng J 2017, 307, 650-660.

2.1 Introduction
Peroxydisulfate, or persulfate, has been investigated for its ability to degrade recalcitrant
organics49-51. Stable at room temperature, persulfate can be activated via heat, transition metals,
ultraviolet (UV) light, or other means, forming the highly reactive sulfate radical (Equation 2.1)
49, 52, 53

.

(2.1)

S2O82- + activator → SO4 -∙ + (SO4 -∙ or SO4 2-)

Like the hydroxyl radical 54, the sulfate radical has a high oxidation potential (Eo=2.60V)55,
and is nonselective56,
remediation,49,

58, 59

57

. Activated persulfate has widespread application for environmental

as formed radicals react with organic chemicals causing either partial or

complete mineralization60-62. In situ remediation with activated persulfate oxidation may be
preferred over peroxide-based hydroxyl-radical oxidation processes, as the persulfate anion is
more stable and may be transported further in the subsurface before being activated for
contaminant degradation63, 64.

5

Tsitonaki et al. (2010) reviewed the use of persulfate for remediation of contaminated soil
and groundwater, focusing on heat, iron and alkaline activations, effects of porous media, and in
situ oxidation65. Enhancing the effectiveness of activated persulfate includes manipulation of
traditional methods and development of novel techniques56, 60, 66-68. Recently, Zhang et al. (2015)
reviewed sulfate radical technologies, covering radicals generated from peroxymonosulfate and
peroxydisulfate52, photochemical and heterogeneous activation systems, in-situ remediation,
hydrothermal oxidation treatment, and air pollution control technologies52.
The following review provides an extensive assessment of recently published parameters
and results for the destruction of various organic compounds in aqueous systems via activated
persulfate. Applicable variables and impacts on activated persulfate reactions are provided.
Emerging methodologies for persulfate activation, such as electrochemical and activated carbon,
are highlighted, along with potential for expanding knowledge areas and obstacles that must be
overcome for future practical implementation.
2.2 Mechanisms of Persulfate Reactions
2.2.1 Sulfate, Hydroxyl, and Other Radical Formation
Heat, UV light, and ultrasound impart energy to the persulfate anion resulting in cleavage of the
peroxide bond and forming two sulfate radicals (Equation 2.2)63, 69. Alternately, persulfate can
undergo an oxidation-reduction reaction with an electron donor from a transition metal or the
radiolysis of water, generating a single sulfate radical (Equation 2.3)70, 71.
(2.2)

S2O82- + energy input → 2SO4-∙

(2.3)

S2O82- + e- → SO42- + SO4-∙

6

Enhancing the effect of activated persulfate degradation reactions are secondary radicals
propagating from sulfate radical reactions65, 72. Sulfate radicals react with water at all pHs forming
hydroxyl radicals (Equation 2.4)71, which are the primary reactive species under basic conditions
(Equation 2.5)73. At pH <7 sulfate radicals are the dominant reactive species; however, hydroxyl
and sulfate radicals participate equally in reactions at neutral pHs73.
(2.4)

SO4-∙ + H2O → SO42- + OH∙ + H+

(2.5)

SO4-∙ + OH- → SO42- + OH∙

(k [H2O] < 2.7 x 10-3 s-1 )

While hydroxyl radicals degrade a wide range of organic contaminants 4, chain reactions
(Equations 2.6 and 2.7) synthesize more reactive intermediates63. Likewise, peroxymonosulfate
(HSO5-) may be activated generating sulfate radicals, as hydrogen peroxide may react with
inorganic compounds producing additional free radicals. The formed radicals can subsequently
participate in further reactions74, 75.
(2.6)

SO4-∙ + OH∙ → HSO5-

(2.7)

2OH∙ → H2O2

2.2.2 Degradation Mechanisms
Sulfate radicals react with organic molecules through hydrogen abstraction, addition on double
bond, and electron transfer76. Because the sulfate radical is electrophilic, electron-donating groups
will have faster reaction rates with the sulfate radical than electron-withdrawing groups65.
Persulfate will react with some organics directly, forming sulfate radicals that propagate secondary
reactions (Equation 2.8) or may create organic radicals (Equation 2.9)57,
decomposing the intended contaminant53,

62, 78

7

.

77

, progressively

Overall contaminant degradation rates are

dependent on a complex combination of the sulfate radical chain propagation and terminating
reactions.
(2.8)

S2O82- + R → SO42- + SO4-∙ + R*

where R represents the organic and R* the

oxidized organic
(2.9)

S2O82- + R → 2SO4-∙ + R∙

2.3 Degradation Reactions by Activation Type
Without activation, the persulfate anion will react with some organic chemicals, but degree of
removal is less than that obtained using activated persulfate because of the lower oxidation
potential of the persulfate anion (Eo=2.01V)79-83. Persulfate activators and their properties are
critical to the rate and extent of analyte mineralization65, 84-86; therefore, results using various
activators are presented in the following sections.
2.3.1 Iron-Activated Persulfate for Analyte Degradation
Persulfate can be activated through one-electron transfer using metals such as silver, copper, iron,
zinc, cobalt and manganese to form the sulfate radical (Equation 2.10)61, 70, 87, 88.
(2.10)

S2O82- +Mn+ → Mn+1 + SO4 2- + SO4-∙

where M represents the metal

Iron, the most widely studied metal, is an effective activator, relatively non-toxic,
environmentally friendly, and more cost effective than other transition metals89. Ferrous iron
(Fe2+) reacts with persulfate to form the sulfate radical (Equation 2.11), with an activation energy
of 50.23 kJ mol1 90. The second-order rate constant of sulfate radical formation from ferrous iron
is reported as 2 x 101 L mol-1 sec-1 at 22 oC91. Indirect activation of persulfate by Fe0 proceeds via
the pathway of Equation 2.1292. The Fe2+ formed activates the persulfate per Equation 2.1192.
(2.11)

S2O82- +Fe2+ → Fe3+ + SO42- + SO4-∙
8

(k = 2.7 x 101 M-1 s-1 )

(2.12)

Fe0 + S2O82- → Fe2+ + 2SO42-

Insufficient iron concentration causes inefficient persulfate usage, while too much Fe2+
results in the iron scavenging the sulfate radical (Equation 2.13), reducing its effectiveness for
degradation93, 94. The second-order rate constant for this reaction is reported as 4.6 x 109 L mol-1
sec-1 at pH 3-5 and the activation energy is -18 kJ mol-1
(2.13)

88

.

SO4-∙ + Fe2+ → Fe3+ + SO42-

Examples of iron-activated persulfate degradations and conditions contributing to optimal
removal are presented in Appendix Table A1, and BTEX/phenols, pharmaceuticals, phenyls/dyes
and various other organics are shown in Appendix Tables A2-A5.
For iron-activated persulfate, much work has gone into understanding ideal ratios of
contaminant to persulfate to iron that enhance removal of contaminants, including antibiotics.
Successful ratios vary greatly with contaminant and reaction conditions, but almost always involve
excess input of persulfate from 10 to 200 times the molar amount of contaminant95-97. At least a
1:1 persulfate to iron ratio is typically needed to achieve maximum analyte removal61, 98; however,
exact ratios vary with iron forms/states, addition methods and target analytes.
Sequential and continuous addition of iron to activate persulfate for analyte removal has
been explored. Sequential and continuous addition of ferrous (Fe2+) iron achieved success over
batch additions for pharmaceuticals caffeine and phenacetin but not nicotine or ibuprofen 97.
Degradation of bisphenol A was enhanced from 49% to 97% using four sequential additions versus
a single dose of Fe2+, and continuous Fe2+ addition achieved 100% removal using the same amount
of total iron and reaction time (Appendix Table A1)99.
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Results varied when using Fe0 and nano-Fe0 for activation as compared to Fe2+98, 100. Fe0
activates persulfate through a two-step process of ferrous iron generation as shown in equation
2.12 followed by the persulfate activation reaction shown in equation 2.1192. Fe0 provides a
measured release of Fe2+ through its reaction with persulfate, with higher surface areas of microand nano-Fe0 amplifying persulfate activation98, 99, 101. In a side-by-side comparison, Fe0 persulfate
activation resulted in more complete removal of sulfamethoxazole than Fe2+ activation, with 100%
removal achieved in the former case95. In the same study, bimetallic (cobalt/Fe0 and silver/Fe0)
and trimetallic (cobalt/silver/Fe0 and silver/cobalt/ Fe0) plated activators also attained adequate
sulfamethoxazole removal, with plating resulting in sustained persulfate activation in solution 95.
The size of Fe0 has undergone further examination, with micrometric iron particles activating
persulfate to remove 97% sulfamethoxazole in thirty minutes102. Recently, Naim et al. (2016)
demonstrated 95% removal of the pharmaceutical ranitidine with microscale industrial iron scrap,
opening the door for low cost, sustainable activation material that may have broad application for
iron-activated persulfate degradation systems, including the solid iron activated system examined
in Chapter 3103. Chapter 3 studies a sustained system for persulfate activation using solid iron,
based on the need for in-depth development of persulfate to iron ratios and continuous persulfate
activation identified in the preceding paragraphs. This system is applied to the degradation of
ciprofloxacin.
Chelation is a potential method for continuous Fe2+ release and is commonly used for in
situ persulfate activation104,
degradation results

to

105

. Results are mixed, with chelated Fe2+ producing similar

Fe2+ for ciprofloxacin

but

slightly better degradation for

sulfamethoxazole96. EDTA is often used to chelate iron, forming strong Fe2+ complexes, while
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citric acid is used for its biodegradability104, 106. Experiments comparing chelation with citric
acid, oxalic acid and EDTA showed 60% aniline removal was achieved using citric acid chelated
Fe2+ versus 45% using only Fe2+ to activate persulfate (Appendix Table A1)106. Sulfamethoxazole
degradation removal was best achieved using EDTA rather than citric acid to chelate Fe2+, while
both were better than using only Fe2+ (Appendix Table A5)96. Use of the inorganic chelator,
Na2S2O3, for Fe2+ persulfate activation led to equivalent or better contaminant degradation
compared to citric acid and EDTA, and eliminated the TOC introduced by organic chelators107.
2.3.2 Mineral-based activators
Mineral-based activators including magnetite (Fe3O4), nano-magnetite (nano-Fe3O4), goethite (αFeO(OH)) and birnessite (a manganese-based oxide) have been employed for persulfate activation
(Appendix Table A5)108, 109. Unfortunately, minerals at naturally occurring levels have been
proven to have limitations for practical application110. It was suggested that concentrations of
naturally occurring minerals in the soils are not sufficient to effectively activate persulfate110.
Further examination into the ability of thirteen naturally occurring minerals to activate persulfate,
showed seven minerals slowed the persulfate activation while only four (cobaltite, siderite, pyrite,
and ilmenite) significantly enhanced the degradation of the target analytes. It was concluded that
most naturally occurring minerals do not effectively activate persulfate for organic degradation,
possibly due to localized differences in pH or redox potentials at the surface, or functional groups
on the surface that may scavenge radicals111. For specific minerals, including some Fe(III) and
Mn(IV) oxides, mineral content greater than 2% of the aquifer solids increases the persulfate
activation rates and higher percentages of these minerals could effectively aid contaminant
degradation112.
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2.3.3 Heat-Activated Persulfate for Analyte Degradation
Persulfate forms two sulfate radicals through scission of the peroxide bond resulting from
absorption of heat energy (Equation 2.14)69. The activation energy for the reaction is 119 to 129
kJ mol-1, 134 to 139 kJ mol-1, and 100 to 116 kJ mol-1 under neutral, basic and acidic conditions,
respectively87. The rate constant of sulfate radical formation ranges from 1 x 10

-7

sec-1 at 25 oC

to 5.7 x 10-5 sec-1 at 70 oC, and pH 1.391.
(2.14)

S2O82- + heat → 2SO4-∙

Huang et al. (2005) studied heat-activated persulfate degradations of 59 volatile organic
compounds113. Appendix Table A1 and Appendix Tables A6 – A8 list more recent results for
heat-activated persulfate degradation studies. In all experiments, the reaction temperature was
critical, resulting in increased degradation and solubility of the contaminants into the aqueous
phase at elevated temperatures114-117. However, temperature optimization is used to minimize the
energy input required for achieving desired results.

For example, 100% removal of

perfluorooctanoic-acid was accomplished at 60 oC and 90 oC, 60 oC was chosen for further
experiments81.
Comparing conventional to microwave heating for activated persulfate degradation
(Appendix Tables A6-A7) concluded that microwave heating resulted in faster analyte
degradation. It was suggested that microwave heating imparts the required energy more quickly to
activate persulfate115, 118. Although both conventional and microwave heat-activated persulfate
eliminate the need to remove dissolved solids and/or precipitants resulting from metal-catalyzed
activation, heat activation is not typically used to remediate large groundwater zones due to the
required energy input and associated costs119. Furthermore, as the temperature increases, so does
12

the rate of reaction for both sulfate radical formation and the potential scavengers, (e.g. chloride
and bicarbonate ions) with the latter decreasing removal efficiency120.
Simultaneous use of iron- and heat-activated persulfate has produced mixed results49, 100,
121

. In the degradation of 1,4-dioxane at 60 oC, the addition of Fe2+ to the process decreased the

pseudo-first order reaction rate from 0.0365 min-1 to 0.0250 min-1 (Appendix Table A1)49. It was
hypothesized that elevated temperatures increased the rate of Fe3+ formation (Equation 2.11),
resulting in ferric hydroxide precipitant and reaction inhibition49. Further, experiments using Fe0
with microwave heat-activated persulfate also exhibited no enhancement of cyclohexanoic acid or
polyvinyl alcohol removal92, 120. In these cases, it was assumed that reactions of the sulfate radical
and iron at elevated temperatures decreased the effectiveness for organic degradation (Equation
2.13)94.
While the previously mentioned experiments exhibited decreased degradation rates, others
achieved improved results with the addition of iron to heat-activated systems. During the removal
of p-nitrophenol, Fe2+ had positive synergistic effects with heat-activated persulfate below 50 oC,
but as temperatures increased, heat activation was the dominant mechanism (Appendix Table
A6)61. The results suggested that the metal ions scavenged the sulfate radical at elevated
temperatures, negating the synergistic effects observed at lower temperatures. Furthermore,
precipitates formed at the higher temperatures limited the diffusion of persulfate and sulfate
radicals in the solution61.
2.3.4 UV Light Activated Persulfate for Analyte Degradation
Persulfate can be activated via UV light forming the sulfate radical (Equation 2.15)122:
(2.15)

S2O82- + hν→ 2SO4-∙
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The UV energy breaks the O-O bond, similar to heat-activated persulfate, and a quantum yield of
unity has been proven for acidic, basic, and neutral conditions123, 124. The results from UVactivated persulfate degradation are presented in Appendix Table A1 and Appendix Tables A9A10.
With UV activation, the wavelength and UV fluence rate plays an important role in
persulfate activation and organic degradation. The most commonly utilized wavelength is 254 nm
due to decreased reaction time requirements compared to other wavelengths125. A comparative
study using 254 nm and 365nm UV-activated persulfate for polyvinyl alcohol destruction found
that 100% removal was achieved in less than 5 minutes at 254 nm but only 93% removal in 30
minutes was observed using 365 nm, (Appendix Table A10)125. When higher fluence rates were
used to activate persulfate, increased degradation and mineralization of beta-lactam antibiotics
were observed (Appendix Table A9)53. For the removal of acid blue 113, 30 W of power resulted
in a faster removal rate than 14 W (Appendix Table A1)126. Though UV activation is a costeffective alternative to thermal activation, this method is limited as UV light has limited
penetration into water and is unviable in the subsurface112, 118, 127.
The synergistic effects of iron addition on UV-activated persulfate degradation of
carbamazepine were tested and found enhanced removal was achieved by pairing the two methods
(Appendix Table A9)128. Adding 50 mM of Fe2+ to UV-activated persulfate resulted in 95%
removal of phenol in five hours (Appendix Table A10). Although the reaction took longer, a much
lower concentration of persulfate was required to achieve 95% removal when Fe3O4 was added to
the system129.
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2.3.5 Base-Activated Persulfate
Base-activated persulfate is one of the most commonly used techniques to for in situ remediation
and is typically performed by adding sodium or potassium hydroxides to raise the pH between 11
to 12105,

130

.

The base catalyzes the hydrolysis of one persulfate molecule, forming the

hydroperoxide (HO2-) intermediate, which in turn reacts with another persulfate molecule in a oneelectron transfer generating a sulfate radical (Equation 2.16). The reaction is second order with
respect to persulfate and sodium hydroxide105. Hydroxyl radicals are generated from sulfate
radicals as previously illustrated (Equation 2.4).
(2.16)

S2O82- + 2H2O

𝑂𝐻−
→

2SO4- + SO4-∙ +O2-∙ +4H+

Hydroxyl radicals are the dominant reactive species at pH > 12, resulting in widespread
organic degradation, and the superoxide radical may play a role in the extensive reactivity of baseactivated persulfate73, 105, 131.
Although higher base to persulfate ratios increases the reactive oxidizing species in a
system, a 2:1 base to persulfate molar ratio is recommended to achieve neutral conditions at the
end of the reaction for in situ use131. Maintaining base-activation may require additional base to
neutralize the natural buffering capacity of the water and soil or the sulfuric acid generated from
persulfate reactions65,

118, 131

. Unfortunately, elevated base levels may cause changes in soil

dispersion and metal concentrations, as well as increase the formation of scavenging species
resulting in decreased analyte degradation65, 118, 131.
Despite its prevalent use for in situ remediation of groundwater and soils, limited studies
are available to determine ideal reaction parameters for specific recalcitrant organics using baseactivated persulfate. This is in contrast to most activator types, which have been widely studied
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and modified in the lab but not put into practice. Studies in which a wide range of organic analytes
are degraded under variable conditions using base-activated persulfate would enable practitioners
to quickly screen the efficacy of base-activated persulfate for specific remediation projects.
2.4 Unique Methods for Persulfate Activation
2.4.1 Electrochemically-Activated Persulfate for Analyte Degradation
Electrochemical techniques have proven to fully mineralize recalcitrant compounds not degraded
via activated-persulfate alone44,

132

.

By combining electrochemistry and electrochemically-

activated persulfate, superior removal results compared to either technique alone may be achieved,
reducing persulfate and/or electricity usage. Few studies exist that describe the synergistic effects
of combining electrochemistry and activated persulfate. Electrochemically activated persulfate
(EAP) studies fall into two categories: those that use iron as a co-activator and those that use inert
electrodes. These are presented in Appendix Table A11.
Studies investigating EAP without iron suggest persulfate activation, through direct
electron transfer at the cathode, creates sulfate radicals (Equation 2.3)59, 133. Activated persulfate
at the cathode is predicted to work in tandem with anodic electrochemical advanced oxidation
processes (EAOP) to degrade organic constituents. The EAOP mechanism is attributed to
hydroxyl radical formation (Eo = 2.74 V) that can occur at anode surfaces such as boron-doped
diamond (BDD), tin dioxide, and lead dioxide (Equation 2.17)44, 45, 47, 134, 135. These hydroxyl
radicals react to degrade organic contaminants and propagate other radicals, which can participate
in degradation reactions44, 45, 47, 134, 135. Additionally, oxidation of the target contaminant by direct
electron transfer at the anode can occur135, 136.
(2.17) H2 O → OH ∙ + H + + e−
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Increased TOC removal was observed for dinitrotoluene and aniline degradation using
electrochemically-activated persulfate versus an electrochemical system without persulfate50, 59.
Both studies found that the contaminant removal increased with the applied potential50, 59.
Electrochemical persulfate activation accomplished with inert anodes and cathodes
eliminates the need for iron addition. Because persulfate can be electrochemically generated from
sulfate ions, it has been suggested that persulfate could be regenerated at the anode (Equation 2.18)
after completion of an activated persulfate degradation reaction78, 137-140. In conjunction with
cathodic activation (Equation 2.3), this would perpetuate a source of sulfate radicals.
(2.18)

SO42- + SO4-→ S2O82- + e-

(anode)

Few if any publications are available that conclusively demonstrate persulfate regeneration during
an organic chemical degradation reaction. Proof of this concept may lead to development of
methods that reduce persulfate consumption while achieving desired contaminant removal.
Chapter 4 focuses on understanding the fundamentals and mechanisms of EAP without iron as a
co-activator. EAP is then applied to the degradation of ciprofloxacin.
Moving forward, studies are needed to determine electrode materials, including those
commonly used for organic destruction (BDD, Ti/RuO2-IrO2, and Ti/SnO2-Sb), best suited for
activating persulfate, the relationship between current density and activation, and the synergistic
effects on degradation and mineralization of various classes of organics140. Chapter 4 covers some
of these topics by comparing cathode materials for electrochemical persulfate activation and
studying the relationship between current density and activation. Chapter 5 further explores
variables influencing organic degradation by EAP, by examining anode:cathode size ratios, reactor
configurations, and ciprofloxacin degradation in a complex matrix.
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The effects of adding iron into a persulfate reaction vessel by applying an anodic current
to iron electrodes have been investigated141, 142. Solid iron produces Fe2+ through chemical and
anodic reactions (Equation 2.19), activates persulfate (Equation 2.11), and can be regenerated at
the cathode (Equation 2.20) for additional persulfate activation141. Some studies found that the
amount of iron added to solution is proportional to the applied current, thus controlling and
enhancing the persulfate reaction through a slow release of iron, similar to other slow release
methods that enhance degradation reactions96, 97, 141.
(2.19)

Fe0 → Fe2+ + e-

(2.20)

Fe3+ + e- → Fe2+

Fe2+ generated from solubilized Fe3+ at the cathode can also activate persulfate (Equation
2.11)141, 143. The use of ferric iron to electrochemically generate ferrous iron resulted in significant
achieved 76.5% bisphenol A removal.

Optimized conditions of low pH, high persulfate

concentration and high current density improved the removal to 100%143.
Electrochemical generation of ferrous iron for persulfate activation, if controlled by
current, may eliminate the need for further iron dosing. However, more work is needed to verify
that Fe2+ recycling reduces iron requirements while achieving the same degradation results as
traditional iron addition. Additionally. the synergistic effects of iron and electrochemicallyactivated persulfate on organic degradation, especially with regard to mineralization and the initial
form of iron, are needed. Chapter 3 addresses these topics with an in-depth exploration of
electrochemically-enhanced iron activated persulfate for the degradation of ciprofloxacin.
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2.4.2 Ultra-sonication, Activated-Carbon, and Other Methods of Persulfate Activation for
Analyte Degradation
Current publications covering lab-scale experiments of various novel activated-persulfate
techniques are presented in Appendix Table A12. Degradation by ultrasonically-activated
persulfate has shown promising results56, 58, 144. Localized high temperatures and pressures from
ultrasonically produced cavitation result in homolysis of the O-O bond producing two sulfate
radicals in the same energy-induced mechanism as heat and UV light radical generation52. The
degradation of ammonia perfluorooctanoate significantly increased by combining persulfate and
ultra-sonication (Appendix Table A12)56. Combining ultra-sonication with persulfate and Fe0
achieved 99.1% removal of sulfadiazine versus only 50% using Fe0 activated persulfate 144.
The addition of persulfate to gamma-irradiated for the destruction of ibuprofen achieved
the same removal using less radiation, while combining persulfate/electron beam to degrade phydroxybenxoic acid did not enhance removal (Appendix Table A12)60, 66. Inducing a weak
magnetic field on Fe0 added to persulfate increased the removal rate of caffeine, 4-nitrophenol,
benzotriazole and diuron and increased TOC removal of orange G from 7.6% to 36.4% in three
hours86.
Activated carbon (AC) was found to activate persulfate by a mechanism postulated by
Liang et al. (2009) and shown in Equations 2.21 and 2.22145.
(2.21)

AC surface-OOH + S2O82- → SO4-∙ + AC surface-OO∙ + HSO4-

(2.22)

AC surface-OH + S2O82- → SO4-∙ + AC surface-O∙ + HSO4-

Greater removal of perfluorooctanoic acid and trichloroethylene was achieved for an ACpersulfate system than could be accounted for through adsorption using AC alone67, 145. The
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synergistic effects of persulfate and granular activated carbon (GAC) enabled the mineralization
of azo dye acid orange 7146 and the GAC was reused several times. Activated carbon fiber has
also been shown to activate peroxymonosulfate147, thus showing potential for peroxydisulfate
activation.
Activated carbon is ubiquitous in water treatment, so widespread potential for adaption of
an AC-persulfate process exists. The advantages over current AC systems include: decreased
carbon usage rate (as the contaminant would be more fully mineralized by the persulfate rather
than taking up sites on the carbon surface) and greater mineralization of the contaminant itself.
2.5 Additional Factors Influencing Activated Persulfate Degradation Reactions
2.5.1 Effects of Persulfate Concentration on Analyte Degradation
It has been widely recognized that analyte removal rate increases as the amount of persulfate
increases49, 106, 148. Typical analyte to persulfate ratios range from 1:20 to 1:250, as shown in
Appendix Tables A1-A12, but effective analyte removal has been achieved using a minimum
molar ratio of 1:292, 149. Alternatively, studies suggest there is an optimum amount of persulfate
above which degradation is inhibited by the reaction of excess persulfate with sulfate radicals
(Equation 2.23) reducing the effectiveness organic oxidation82, 120, 150, 151.
(2.23)

SO4 -∙ + S2O82- → SO4 2- + S2O82-∙

Customization of persulfate levels can optimize degradation of target analytes; however,
this is not always feasible in the presence of multiple analytes with different degradation rates or
the presence of scavenging species. While almost always reported as pseudo-first order based on
the analyte concentrations93, 115, 144, 152, reaction rates, in fact, follow second order kinetics with
respect to the analyte and persulfate concentrations. Establishing second-order kinetics and rate
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constants across categories of organic contaminant can help minimize the amount of persulfate
needed to achieve desired results. Chapter 5 examines effects of persulfate concentration on
ciprofloxacin degradation using three reactor configurations. It also evaluates second-order
mechanisms between ciprofloxacin and persulfate on a rotating-disk electrode reactor.
2.5.2 Effects of pH on Analyte Degradation
The pH of the activated persulfate reaction has a significant effect on analyte removal, even in
most cases where pH is below the range required for base activation. Although degradation
reactions at acidic pH most frequently improve the degradation of the contaminants by forming
hydroxyl radicals (Equation 2.4), improved removal was also observed at neutral pH (between 6
and 8) and slightly basic pH (between 9 and 10) depending on the analyte and activator type79, 87,
100, 150, 153-155

.

2.5.3 Interfering Effects of Ions on Activated Persulfate Reactions
Several ions naturally found in groundwater affect activated persulfate degradation of aqueous
contaminants128,

156

. The impacts of bicarbonate and chloride ions for the destruction of p-

nitrosodimethylaniline using different persulfate activation types were studied and concluded that
neither species affected iron-activated reactions at neutral pH. Heat-activated reactions were
enhanced by chloride, while base-activated reactions were improved by the presence of both
chloride and bicarbonate157. Enhanced UV-activated persulfate degradation of acetaminophen was
followed by decreased removal reaction when the chloride concentration was greater than 20
mM158. Citric acid chelated Fe2+ activated persulfate degradation of trichloroethene experienced
no hindrances with 1 mmol L-1 chloride, but removal decreased from 99% to 46% in the presence
of 100 mmol L-1chloride159. Similar results were seen for the microwave heat-activated persulfate
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reaction of sulfamethoxaole118. Enhanced degradation may have occurred as low concentrations
of chloride in solution can react with sulfate radicals forming chloride radicals that can degrade
organic species while high levels may result in sulfate radical scavenging151.
Bicarbonate was observed to have a negative effect on degradation reactions, across the
range of activator types57,

63, 94

. Natural organic matter (NOM) impedes activated persulfate

reactions with reactions tylosin, geosmin, 2-methylisoborneol, atrazine and florfenicol148, 150, 160,
161

.

Subsequent studies for the degradation of 1,4-dichlorobenzene, benzene, and 1,4-

dichloropropane in artificially contaminated water and real groundwater, determined the removal
efficiency decreased in the groundwater due to the competing reaction of NOM with the sulfate
radical162.
2.6 Practical Applications for Activated Persulfate Use in Water Treatment
2.6.1 Wastewater Treatment
Specific wastewater applications, including industrial discharge and landfill leachate, have been
investigated. Microwave heat activated persulfate at 85 oC was shown to remove 79.4% of the
TOC from mature landfill leachate in 30 minutes (Appendix Table A8)163, while an
electrochemical Fe2+ persulfate activation system achieved 62% removal of chemical oxygen
demand from landfill leachate (Appendix Table A11)164. Ibuprofen removal from aqueous
solutions using heat-activated persulfate suggests that this process may be able to treat small
volumes of concentrated effluents from hospitals or pharmaceutical manufacturers (Appendix
Table A7)165. Additionally, heat activated persulfate at 65 oC resulted in 100% removal of the
pharmaceutical bisoprolol in thirty minutes165, 166. In the degradation of the antibiotic florfenicol,
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58.8% mineralization was achieved in two hours with UV/PS versus only 14% in the same time
using UV/H2O2, and with less cost167.
Activated persulfate may have broader applications for treating concentrated effluents
containing a variety of contaminants and pharmaceuticals, including fluoroquinolones,
penicillins, and piperacillins, as well as textile dyes53,

96, 168, 169

. Unfortunately, limitations

regarding persulfate reuse, as well as iron and sulfate removal, must be addressed. The recovery
of nano-Fe3O4 using magnets after persulfate/nano-Fe3O4 reaction enabled the re-use of Fe3O4 up
to four times with minimal leaching into water and was suggested as a cost-effective approach109.
Chapter 5 applies EAP to synthetic hospital effluent to screen this technique for real-world
application. In this final research chapter, the degradation of ciprofloxacin in synthetic hospital
effluent using two reactor configurations is evaluated.
2.6.2 In Situ Groundwater Remediation
The most wide-spread use of activated persulfate includes in situ remediation of contaminated
groundwater130. The subsurface properties affect reactivity and maintaining persulfate/activator
levels in the subsurface are critical for successful implementation162, 170, 171. For instance, soil
organic matter under basic conditions enhanced activated persulfate degradation of nitrobenzene
and hexachloroethane, while a subsequent study proposed that activation by phenols contained in
the soil was partially responsible110, 171. Superior removal of diclofenac was exhibited in real
groundwater containing naturally occurring mineral ions as opposed to reactions in deionized
water172. The exhibited enhancement contrasts with previous studies showing ions interfering with
analyte degradation may be due to the differences in the ion species found in groundwater at
various locations.
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Properties of the organic species and the subsurface regions can affect the degradation of
contaminants. For instance, though catalyzed hydrogen peroxide propagations can enhance
removal of hydrophobic compounds sorbed to soil and subsurface solids, the same result was not
accomplished using activated persulfate119. Preferential reactions between activated persulfate
with soil organic matter may reduce adsorption of contaminants onto soils, enabling mobilization
of the contaminants into uncontaminated regions91. A study into the effects of aquifer solids on
persulfate activity determined that exhaustion of persulfate and activating agents inhibits longterm availability of persulfate170.
Studies for overcoming the challenges and limitation of persulfate and activator
maintenance have been undertaken. A proposed solution to maintain iron levels in situ is the use
of hydroxylamine to quickly cycle Fe3+ back to Fe2+ has proven successful for completely
degrading trichloroethylene (Appendix Table A1)173. Permeable reactive barriers can provide
continuous persulfate release overcoming depletion issues while enabling the degradation of
contaminants174. Slow release persulfate-paraffin-Fe0 candles have been utilized to maintain
activated persulfate concentrations for the removal of BTEX compounds175.
2.7 Conclusions and Outlooks
Extensive review of recently published results confirms activated-persulfate is a viable method for
the destruction of organic analytes for soil and groundwater remediation. Using optimized
conditions, 100% removal can be accomplished for some recalcitrant organics. Unfortunately,
challenges remain to optimize degradation reactions for efficient, cost-effective and timely
contaminant removal in practical systems.
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Development of methods to maintain persulfate and activator concentrations will improve
utilization in situ. Broader understanding of environmentally friendly iron-chelator functionality
under groundwater conditions will help identify cases where chelators can improve longevity of
iron. At the same time, practitioners can move away from using traditional chelators that are now
considered undesirable environmental additives. Determining second-order reaction kinetics
between persulfate and analytes in the presence of chelated iron may help enhance optimization of
reaction longevity. Relating subsurface parameters, including mineralogy and NOM, to activated
persulfate degradation outcomes, will enable efficient assessment and prediction of activated
persulfate treatment outcomes. Finally, physical techniques offering slow releases of persulfate
into groundwater systems have been successful; however, supplementary experiments covering a
broader range of chemicals and reaction conditions are needed.
Studies comparing or correlating organic degradation using persulfate activator type,
particularly under groundwater or wastewater conditions, will offer a better understanding of the
reaction mechanism and outcomes for activated persulfate degradation of various classes of
organic species. Formulation of practical guidelines would increase the ability to theoretically
predict and achieve desired degradation outcomes.
Studies regarding the cost-effectiveness of energy input versus degradation outcomes for
energy-intensive activation methods, including heat, UV light, ultra-sonication and
electrochemical, may have repercussion for implementation of activated persulfate. Persulfate is
often successful for destroying relatively concentrated pollutants and removing recalcitrant
organics at the site of contamination. Nonetheless, little work has been done to combine activated
persulfate reactions with subsequent sulfate ion removal such as ion exchange or filtration. As
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coupling different processes may be required for implementing activated persulfate in certain
systems, assessment of the additional costs of sulfate ion removal against the potential to remove
certain contaminants or by-product is necessary.
Although reaction outcomes typically improve with increased persulfate addition, the
“more is better” approach can lead to wasted resources and depletion of reactants, limiting
degradation of targeted contaminants. Improved understanding of second-order reaction rates with
respect to both analyte and persulfate can allow for optimization of persulfate usage in specific
systems. The novel technique of electrochemical persulfate activation may minimize persulfate
or iron usage through regeneration, resulting in better mineralization than some other activation
techniques. Other novel techniques may also be advantageous for complete contaminant removal
or mineralization; for instance, activated-carbon can function as both a catalyst for persulfate
activation and adsorbent for removal of some contaminants and by-products. Implementation of
these novel methods requires follow-up studies verifying their usefulness for promoting effective
activated persulfate degradation and refined parameters for practical application.
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CHAPTER THREE: SUSTAINED PERSULFATE ACTIVATION USING SOLID IRON:
KINETICS AND APPLICATION TO CIPROFLOXACIN DEGRADATION
This chapter is revised based on a paper published by Laura W. Matzek and Kimberly E. Carter,
as follows:
Matzek, L. W.; Carter, K. E., Sustained persulfate activation using solid iron: Kinetics and
application to ciprofloxacin degradation. Chem Eng J 2017, 307, 650-660.
3.1 Background
Limited studies have examined the use of Fe0 in the form of solid iron bars/rods to sustain a
controlled persulfate degradation reaction141, 142. With this method, current is applied to an iron
electrode to electrochemically augment (Equation 2.19) the chemical corrosion of solid iron
(Equations 2.12 and 3.1) into solution where it can react to activate persulfate (Equation 2.11)92,
141, 153

. Additional ferrous ions are produced at the surface of the solid iron per equation 3.2153.

Excess ferrous ions in solution may scavenge persulfate radicals via equation 2.13, decreasing the
efficiency of persulfate to degrade the intended compound98, 142.
(3.1)

Fe0 + O2 + 2H2O → Fe2+ + 4OH-

(3.2)

Fe0 + 2Fe3+ → 3Fe2+

Govindan et al. (2014) demonstrated degradation of pentachlorophenol (PCP) using an iron
anode and cathode to activate persulfate142. Successively larger first-order PCP degradation rate
constants were observed with increasing applied current142. Yuan et al. (2014) manipulated
persulfate activation using current applied to an iron anode. It was established that the iron
production increased with current and that a linear relationship (R2=0.933) between iron
production rate and persulfate decomposition existed when measured with analyte in solution. A
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linear relationship between current and the trichloroethylene first-order reaction rate constant was
also established141.
It is postulated that solid iron activated persulfate offers an avenue for optimizing persulfate
to iron ratios and minimizing the amount of iron needed to sustain the persulfate activation
reaction. Solid iron may be advantageous over zero-valent nano- micro- and granular iron because
unreacted amounts can more easily be removed from solution upon reaction completion. The
addition of current or manipulation of surface area, which is simpler to accomplish with solid iron
versus other forms, is expected to provide a way to control the solid iron dissolution rate. The
current-regulated introduction of iron into the system should enable both controlled and sustained
persulfate activation. The first stage of this study aimed to enhance current knowledge of solid
iron activated persulfate systems by determining the fundamental relationships between iron
surface area, applied current, iron production and persulfate activation. These experiments were
completed without analyte in solution, a step often bypassed in current research which is critical
to provide a foundation for the use of solid iron activated persulfate for environmental contaminant
removal. The objective of the second stage of this study was to demonstrate the efficacy of solid
iron activated persulfate in degrading environmental contaminants. The fluoroquinolone antibiotic
ciprofloxacin was used as a model compound. Ciprofloxacin has been successfully degraded with
granular ferrous iron activated persulfate and its use in this study is intended to provide an
understanding of the solid iron activated persulfate process96.
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3.2 Materials and Methods
3.2.1 Chemicals
Acros Organics ciprofloxacin (98%) was purchased from Fisher Scientific (Pittsburg, PA).
Sodium persulfate (98%) was purchased from Fisher Chemical. Iron rods were purchased from
Sigma Aldrich (99.98%, 6.3 mm diameter). Electron Microscopy Science graphite rods (0.120inch diameter) were purchased from Fisher. Other chemicals include 100 ppm fluoride standard
(ThermoScientific Orion Ionplus Application solution), 1N sulfuric acid (J.T. Baker), Optima
formic acid (Fisher Scientific), nitric acid (Fisher Scientific), hydrochloric acid, (Fisher Scientific)
sodium hydroxide (Fisher), Optima Methanol (Fisher Chemical), potassium iodide (99+%, Acros
Organic from Fisher), potassium sulfate (Fisher Scientific), sodium bicarbonate (Fisher Scientific),
tert-butanol (Fisher) and Ferrover iron reagent powder pillows (Hach®, Loveland, CO). Deionized
water (DI) (18.2 MΩ-cm) was generated by a Millipore Milli-Q system for all experiments.
3.2.2 Experimental Procedures
Physical Setup: All experiments were completed at 20 °C. Iron rods were rinsed with aqua Regia
(3:1 hydrochloric acid to nitric acid) then DI water to ensure starting uniformity of the surface for
each run176. 700 mL volumes were used for all experiments. All experiments were completed at
least in duplicate. Stirring was maintained for the duration of each experiment using a magnetic
stir bar. An iron rod was inserted to a depth corresponding with the desired surface area at time =
0 (immediately after first sampling). Surface areas were chosen based on the range of areas
attainable within the physical limitations of iron rod and iron rod holder. For each series with
applied current, a graphite rod was inserted 7 cm from the iron rod, to a depth of 4 cm. A constant
current was applied to these systems with the positive terminal connected to the iron rod and the
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negative terminal connected to the graphite rod. Current density was adjusted by adjusting current
at a constant surface area. The physical set-up is illustrated in supplementary Figure 3.1.
Persulfate Activation Experiments: For each time series, 200 mL of a prepared 63 mmol
L-1 sodium persulfate solution was mixed with 500 mL deionized water in an open 1 L beaker.
The solution was stirred at 750 rpm for 5 minutes and sampled. 3 mL samples were taken at predesignated time intervals and frozen to quench the persulfate activation reaction. The initial
persulfate concentration was chosen to correspond with that used in ciprofloxacin degradation
experiments as outlined in section 2.2.3. The pH was not controlled or buffered during the
experiment to better examine natural reaction pathways of the system104, 141, 177. Initial pH values
averaged 3.5, similar to initial reaction conditions of some other persulfate-based experiments101,
104, 178

. Final pH values averaged 2.5, a drop in pH noted in several studies and attributed to

generation of acid during persulfate decomposition104, 177.

Figure 3.1. Schematic of iron-activated persulfate experimental setup
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Ciprofloxacin degradation experiments: Batches of ciprofloxacin were prepared in 0.338
mmol L-1 concentration with 0.1% sulfuric acid (to aid dissolution) at least one day before
experiment (also to ensure complete dissolution)44. For each time series, 200 mL of a prepared 63
mmol L-1 sodium persulfate solution was added to an open 1 L beaker. A predetermined amount
of 0.338 mmol L-1 solution of ciprofloxacin was added to achieve the desired initial concentration
(for example, 250 mL was added to reach 0.121 mmol L-1 in the final 700 mL mixture). An initial
concentration of 0.121 mmol L-1 ciprofloxacin was used for all degradation experiments unless
otherwise noted. This initial concentration falls within the range used in related pharmaceutical
degradation experiments44, 96, 97, 176. It is above concentrations typically found in the environment
in order to facilitate analysis of ciprofloxacin and avoid errors associated with dilution when
working on the low microscale97. The persulfate concentration was chosen to achieve a 1:150
molar ratio of ciprofloxacin to persulfate. This ratio is within the range established by other
successful contaminant degradation studies incorporating iron activated persulfate96, 97, 179. An
appropriate amount of water was added to attain a total volume of 700 mL. The solution was
stirred at 750 rpm for 5 minutes and sampled. The solution was then stirred an additional 25
minutes and sampled before insertion of iron rod, for a total of 30 minutes of stirring before iron
rod inserted. All tests, with and without applied current, were completed using a constant iron
surface area of 6.1 cm-2. This surface area was high enough to minimize effects of surface area to
reaction volume changes as samples were taken, while keeping the amount of iron introduced into
the system to a minimum. 15 mL samples were taken at pre-designated time intervals and frozen
to quench the persulfate activation reaction. As previously mentioned, pH was not controlled
during the experiment to better investigate reaction pathways of the system104, 141, 177. Initial pH
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values averaged 4.0 upon mixing of ciprofloxacin and persulfate and final pH values averaged 2.5
after 120 minutes of reaction. The ciprofloxacin was extracted after 24 hours as outlined in section
2.3.2. Radical scavenging experiments were completed using the same methodology but with the
addition of 220 mmol L-1 methanol or tert-butanol.
3.2.3 Analytical Methods
Persulfate and Iron Analysis: Persulfate concentration was analyzed using a ThermoScientific
Evolution 600 UV-Vis spectrometer (ThermoFisher, Pittsburg, PA) at a wavelength 352nm, based
on a modification of the spectrophotometric technique180, 181. A 1 mol L-1 solution of potassium
iodide (KI) containing 0.15 mmol L-1 sodium bicarbonate was prepared using high purity water
(18.2 mΩ). For each analysis, 40 μL of persulfate sample was combined with 1 mL the potassium
iodide-sodium bicarbonate solution to give an approximate molar ratio of 1:1000 persulfate to KI
providing an overabundance to react with the persulfate. A 20-minute wait time followed, to allow
a yellow color, created from the reaction of persulfate with potassium iodide to form iodine, to
develop. The sample was diluted to an absorbance level within the calibration range by adding
9.5 mL of DI water and mixing. Each sample was measured against of background of potassium
iodide-sodium bicarbonate solution.

Calibration standards with known amounts of sodium

persulfate were prepared and measured using the same technique. The linear dynamic range of
the calibration curve is 4 to 120 µmol L-1 persulfate as diluted and measured, which corresponds
to original sample concentrations of 0.8 mmol L-1 to 30.7 mmol L-1 persulfate. The method
detection limit was 0.6 mmol L-1 persulfate in original, non-dilute samples. See additional
statistical analysis in Table 3.1.
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Table 3.1. Statistical Parameters for Persulfate Calibration Curve

Value
Standard error
R2

Slope
(absorbance unit per µmol L-1)
0.0245
0.00033
0.9995

Abs.
-0.0415
0.0315

Total iron concentration was analyzed using a ThermoScientific Evolution 600 UV-Vis
spectrometer (ThermoFisher, Pittsburg, PA) at a wavelength of 510 nm, based on a modification
of the spectrophotometric technique created by Hach® for use with their Ferrover iron reagent
powder pillows for 5mL samples. These powder pillows make use of the 1,10 phenanthroline
method. A small amount of sample solution (100-200 μL) was added to 5 mL of DI to dilute
sample within analysis range of powder pillows. One Ferrover powder pillow was added to each
diluted sample and allowed to react for 5 minutes before absorbance was measured. Standards
were prepared and measured using the same procedure.

The linear dynamic range of the

calibration curve was 5.6 to 261 µmol L-1 total iron as diluted and measured. Sample dilution
factors were adjusted from as needed so that samples ranging from 0.146 mmol L-1 to 13.3 mmol
L-1 could be measured. The method detection limit was 0.08 mmol L-1 iron in original sample.
See additional statistical analysis in Table 3.2.

Table 3.2. Statistical Parameters for Iron Calibration Curve
Value
Standard error
R2

Slope
(absorbance unit per µmol L-1)
0.0113
4.38E-05
0.9999

Abs.
-0.0279
0.00635

Ciprofloxacin analysis: Ciprofloxacin concentration was analyzed using a Thermo
Scientific

Evolution 600 UV-Vis spectrometer at a wavelength of 272nm (ThermoFisher,
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Pittsburg, PA). To prepare for analysis, ciprofloxacin was extracted from the sample to avoid
absorbance interference by iron. Prior to extraction, the pH of each sample was lowered to 1.5
using sulfuric acid. This adjustment to a low pH provided >98% extraction efficiency during
development of the extraction method, versus 90% extraction efficiency at a pH of 3.0, and 80%
efficiency at a neutral pH, so pH adjustment by sulfuric acid was established as part of the method.
As >98% of the ciprofloxacin was recovered, it was assumed that hydrolysis did not occur under
the low pH conditions. Ciprofloxacin was extracted using solid-phase extraction with Waters SepPak tC2 cartridges. Cartridges were conditioned with 1mL methanol and rinsed with 1mL of DI
water. 0.5mL of sample was loaded onto cartridge followed by a 0.5mL rinse with DI to remove
all iron from cartridge. The sample was eluted under vacuum with three subsequent 1mL quantities
of a methanol/0.1% formic acid solution. Extracted ciprofloxacin samples were quantified using
standards prepared in methanol/0.1% formic acid. The linear dynamic range of the calibration
curve was 1.1 to 83 µmol L-1 ciprofloxacin, which corresponds to 0.003 to 0.250 mmol L-1
ciprofloxacin before dilution by the extraction process. The method detection limit was 0.003
mmol L-1 in the original, non-dilute samples. (See additional statistical analysis in Table 3.3.)

Table 3.3. Statistical Parameters for Ciprofloxacin Calibration Curve
Value
Standard error
R2

Slope
(absorbance unit per µmol L-1)
0.1148
0.00164
0.9994

Abs.
-0.0283
0.0261

Ciprofloxacin extracts were diluted 1:25 in methanol and analyzed for intermediates and
transformation by-products using a Thermo Scientific Exactive™ Plus Orbitrap LC-MS with
ultimate 3000 RS pump, column compartment, autosampler, and diode array detector
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(ThermoFisher, Pittsburg, PA) with scan range 50-500m/z; resolution 140,000; positive mode
electrospray ionization; AGC target 3e6; max inject time 200ms. The ESI settings were: sheath
gas 25, aux gas 6, sweep gas 3, capillary temp 300oC. The column temp was 30 C; UPLC with
mobile phase 80:20 MeOH:H2O with flow rate of 0.2mL/min, 10-minute run, 10 µL was injected.
UV-vis at 272nm and 3D field from 200-400nm. The linear dynamic range of the calibration curve
for ciprofloxacin was 1.2 µmol L-1 to 193 µmol L-1. The limit of detection for the ciprofloxacin
analysis was less than 1.2 µmol L-1. See additional statistical analysis in Table 3.4.

Table 3.4. Statistical Parameters for HPLC-MS Calibration Curve
Value
Standard error
R2

Slope
(peak area per µmol L-1)
5.42E-07
3.82E-09
0.9999

Fluoride Ion Analysis:

Peak Area
n/a
n/a

Fluoride ion (F-) concentrations were analyzed using ion

chromatography. In preparation, the pH of all samples was raised to 7 to precipitate iron and
dissociate any hydrofluoric acid that may have formed during the degradation process. Samples
were then filtered through successive 3.1, 1.2, 0.7 µM ThermoScientific™ Target 2™ glass
microfiber syringe filters and 0.45 µM polypropylene hydrophilic syringe filters to remove
particulates. Samples were transferred to low-density polyethylene (LDPE) IC vials in preparation
for ion chromatography (IC; Thermo-Element, FL) using a Dionex 2100/1100 dual column system
with background suppression. F- ions were quantified using a standard calibration curve. The
linear dynamic range of the calibration curve was 10.5 to 526 µmol L-1 F- ions. The analytical
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detection limit of the IC for fluoride analyte was less than 5.2 µmol L-1 F- ions. See additional
statistical analysis in Table 3.5.
Total Organic Carbon Analysis: Total organic carbon (TOC) was determined using a
Shimadzu TOC-L analyzer with autosampler ASI-L. In preparation, the pH of all samples was
raised to 7 to precipitate iron and dissociate any hydrofluoric acid that may have formed

Table 3.5. Statistical Parameters for Fluoride Ion Calibration Curve

Value
Standard error
R2

Slope
(µS*min per µmol L-1)
0.007925
9.27E-05
0.9993

Intercept
(µS)
-0.0251
0.0210

during the degradation process. Samples were then filtered through successive 3.1, 1.2, 0.7 µM
ThermoScientific™ Target 2™ glass microfiber syringe filters and 0.45 µM polypropylene
hydrophilic syringe filters to remove particulates. The linear dynamic range of the calibration
curve was 146 µmol L-1 to 4167 µmol L-1 TOC. The method detection limit for the TOC analysis
was 52 µmol L-1 TOC. See additional statistical analysis in Table 3.6.

Table 3.6. Statistical Parameters for TOC Calibration Curve

Value
Standard error
R2

Slope
(mV*min per µmol L-1)
2357
1286
0.9996

Intercept
(mV*min)
40.86
21.46
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3.3 Results and Discussion
3.3.1 Persulfate Activation Experiments
Persulfate activation controlled by current applied to iron: Persulfate activation is represented by
persulfate decomposition, which is inversely proportional to radical formation. Figure 3.2a shows
the decrease in persulfate with time when exposed to solid iron with and without an applied current
and no analyte present in solution. The R2 correlation coefficients of >0.97 for a linear relationship
between persulfate decomposition and time for all series (Table 3.7) establish that persulfate
decomposes through a zero-order mechanism when exposed to a solid iron surface. For a constant
surface area of 6.1 cm2, a persulfate reaction rate constant of 4.3 x 10-7
mol L-1 s-1 was found, while an average maximum reaction rate constant of 7.1 x 10-7 mol L-1 s-1
at higher current densities was achieved. See Table 3.7 for reaction rate constants at all current
densities.
The chemical corrosion of iron due to acidic conditions contributed to over 55% of the
maximum persulfate decomposition rate achieved with use of applied current, based on a
comparison of reaction rate constants with no current and with applied current using equation 3.3.
(3.3)

Contribution to persulfate activation by chemical corrosion

(Avg. max. reaction rate constant − Reaction rate constant with no current)
𝑋 100
Avg. max. reaction rate constant
The “average maximum reaction rate constant” is the average of all reaction rate constants
for current densities greater than or equal to 8.2 mA cm-2. At or above current densities of 8.2 mA
cm-2, all reaction rate constants are +/- 5% of a horizontal plateau, as shown in Figure 3.3b.
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Figure 3.2. Persulfate decomposition by solid iron
(a) Persulfate decomposition by solid iron with and without applied current, as a function of time.
R2 = 0.9857 for 0 mA cm-2. R2 = 0.9838 for 3.3 mA cm-2 . R2= 0.9930 for 11.5 (b) Persulfate
decomposition as a function of iron production, shown at no current.cm-2. The linear fits indicate
a zero-order reaction mechanism between the solid iron and persulfate at all current densities. R 2
= 0.9907. The linear correlation suggests iron dissolution as the driving factor in persulfate
decomposition. Initial persulfate concentrations were 18 mmol L-1, iron surface area=6.1 cm2.
Error bars represent 95% interval. pH was not controlled. The final pH of all experiments at 240
minutes was 2.5.
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Applied current enhanced iron production above levels achieved with the naturally
occurring acidic conditions of the system. Figure 3.2b displays the relationship between iron
production and persulfate decomposition without current applied. A similar linear relationship
exists at all current densities tested, with R2 values > 0.98, as shown in Table 3.8. The slope of the
line elucidates the average molar decomposition of persulfate per mole of iron produced, or the
persulfate to iron ratio (PS:Fe). Without electrochemical supplementation, every 1.00 mole of iron
production resulted in 1.14 moles of persulfate consumed for the duration of each experiment.
With equation 2.12 a proposed mechanism of ferrous iron dissolution into solution, one mole of
zerovalent iron should decompose one moles of persulfate, and then the same iron, now ferrous,
would decompose another mole of persulfate per equation 2.11 to generate sulfate radicals, giving
an overall 2:1 PS:Fe ratio. The near 1:1 ratio can be attributed to the acidic reaction conditions of
this study. In this case, the oxygen reactions with iron under acidic conditions are also a factor in
iron production according to equations 3.4 and 3.5182. More ferrous iron is made available to
generate sulfate radicals without the unproductive persulfate decomposition indicated in equation
2.12.

A Fenton reaction, generating additional hydroxyl radicals to degrade the intended

contaminant, may result from the reaction between H2O2 generated according to equation 3.5 and
the ferrous iron182.
(3.4)

Fe0 + O2+4H+→ 2Fe2+ + 2H2O

(3.5)

Fe0 + O2+2H+→ 2Fe2+ + H2O2

Figure 3.3a shows the PS:Fe ratio as a function of current density. With applied current,
there is the possibility of activating persulfate through direct electron transfer (Equation 1.3), a
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Table 3.7. Statistical Parameters for Figure 3.2a.
Current Density
(mA cm-2)

Parameter

0.0

Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2

3.3

6.2*

8.2*

11.5

Slope (zero-order reaction
rate constant)
(mmol L-1 persulfate min-1)
-0.0258
0.00068
0.9857
-0.0347
0.0010
0.9838
-0.0371
0.00086
0.9915
-0.0407
0.0023
0.9581
-0.0415
0.0009
0.9930

*not shown on figure
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Intercept
(mmol L-1 persulfate)
17.87
0.0850
17.45
17.45
0.123
18.25
0.130
17.64
0.318

17.72
0.1065

Table 3.8. Statistical Parameters for Iron Dissolution Versus Persulfate Reduction
Current Density
(mA cm-2)

Parameter

0.0

Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2

3.3*

6.2*

8.2*

11.5*

Slope
(mmol L-1 persulfate /
mmol L-1 iron)
-1.14
0.0254
0.9907
-1.06
0.0316
0.9851
-0.977
0.0207
0.9928
-0.988
0.0414
0.9760
-1.00
0.0266
0.9895

Intercept
(mmol L-1 iron)
17.93
0.0845
17.41
0.121
18.42
0.122
17.83
0.246

17.91
0.141

*not shown on figure

Figure 3.3a shows the PS:Fe ratio as a function of current density. With applied current, there is
the possibility of activating persulfate through direct electron transfer (Equation 1.3), as well as
the possibility of regenerating Fe2+ from Fe3+ at the anode (Equation 1.20), introducing more
ferrous iron into solution for persulfate activation71, 141. If these mechanisms play a significant role
in persulfate decomposition, it would be expected that the PS:Fe ratio would increase with current.
In fact, the efficiency of iron use decreased slightly with applied current, with 1.00 mole of iron
production resulting in 1.00 mole of persulfate decomposed (+/- 5%), at all applied current levels.
While the electrochemical activation or persulfate and ferrous ion regeneration are theoretically
possible, they do not play significant roles in the overall decomposition rate.
Figure 3.3b illustrates the iron production rate and zero-order persulfate reaction rate
constant as a function of current density. These inter-related variables follow the same trend, with
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Figure 3.3. Persulfate-iron relationships as a function of current
(a) Molar ratio of persulfate decomposition to iron production as a function of current density.
The solid horizontal line illustrates the average ratio. (b) Iron production rate and zero-order
persulfate reaction rate constant as a function of current density. Initial persulfate concentration
was 18 mmol L-1, iron surface area=6.1 cm2. Error bars represent 95% interval.
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an increasing reaction rate as current density increases to 8.2 mA cm-2. The plateau above 8.2mA
cm-2 is attributed to diffusion limitations of reactants entering and leaving the surface, which is
associated with the surface dominated zero-order reaction rate. Reaction rate limits are an
important consideration for use of solid iron as a persulfate activator, since the limiting current
density should be quantified in order to maximize persulfate activation without excess electricity
used.
Persulfate decomposition controlled by iron surface area:

It was postulated that

manipulating the surface area of solid iron exposed to solution controls the persulfate activation.
Figure 3.4 shows persulfate decomposition at iron surface areas of 3.2 cm2, 6.1 cm2, 9.4 cm2 and
12.8 cm2. The linear trends of each time series, with R2 values >0.95 (Table 3.9), indicate that
persulfate decomposes by a zero-order mechanism. Within the surface areas tested, there were no
limiting conditions. The largest reaction rate constant was found at the largest surface area, with
an average value of 8.4 x 10-7 mol L-1 s-1.

The reaction rate constant increased close to

proportionally with an increase in iron surface area. Increasing the surface area by a factor of 2.1
garnered an 18% improvement in comparison the maximum reaction rate achieved with applied
current. In Figure 3.5, by increasing the surface area, iron production and persulfate activation
followed similar linear trends. Parameters and statistical details can be found in Table 3.10. The
reaction rate constant for persulfate, as a function of iron surface area, can be modeled as shown
in equation 3.6.
(3.6)

k0,ps =7.2 x 10-8 x A – 6.1 X 10-8

The k0,ps is the persulfate reaction rate constant (mol L-1 s-1) and A is surface area of iron
(cm2). Iron utilization was 1.14 moles of persulfate decomposed for every 1 mole of iron released.
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Figure 3.4. Persulfate decomposition by solid iron at different iron surface areas
Displayed as a function of time. The linear fits indicates a zero-order persulfate activation
mechanism at all iron surface areas. Initial persulfate concentration was 18 mmol L-1. Error bars
represent 95% interval. pH was not controlled. The final pH of all experiments at 240 minutes
was 2.5.

Table 3.9. Statistical Parameters for Figure 3.4.
Iron Surface Area
(cm2)

Parameter

3.2

6.1

9.4

12.8

Intercept
(mmol L-1)

Value

Slope
(mmol L-1 persulfate
min-1)
-0.00757

Standard error
R2
Value
Standard error
R2
Value
Standard error
R2
Value
Standard error
R2

0.0039
0.9721
-0.0259
0.00065
0.9863
-0.0373
0.0013
0.9839
-0.0503
0.0027
0.9575

0.0644

18.00

17.88
0.0798
17.58
0.189
17.305
0.392
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Figure 3.5. Iron production and zero-order persulfate reaction rate by iron surface area
Iron production rate and zero-order persulfate reaction rate constant as a function of solid iron
surface area. The initial persulfate concentration was 18 mmol L-1. Error bars represent 95%
interval.

Table 3.10. Statistical Parameters for Figure 3.5.
Analyte

Parameter

Iron

Value
Standard error
R2
Value
Standard error
R2

Persulfate

Slope
(mol L-1 s-1 per cm2)
6.526E-08
5.656E-09
0.9500
7.188E-08
4.670E-09
0.9713
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Intercept
(mol L-1)
-7.663E-08
4.757E-08
-6.075E-08
3.927E-08

For surface areas and current densities, the solid iron decomposition of persulfate followed
a zero-order mechanism, which is suggestive of a surface-interface dominated process. Important
implications include (1) persulfate decomposition rate can be finely controlled by iron surface
area, (2) persulfate decomposition can also be enhanced with the use of applied current, but
diffusion limitations exist, (3) the amount of iron required to sustain the persulfate reaction can be
minimized to the lower end of the PS:Fe ratio typically used to degrade contaminants with granular
iron products 48, 52, and (4) solid iron can easily be removed upon reaction completion so that only
the amount of iron required by the chemical reactions is introduced into the system.
3.3.2 Ciprofloxacin Experiments
Mixing phenomena: Before inserting the iron into the reaction container, a reduced ciprofloxacin
concentration was noted after 5 minutes of mixing with sodium persulfate, with a significant
increase in measured ciprofloxacin after 30 minutes of mixing. In a similar manner, Ji et al. (2014)
noted a decrease in ciprofloxacin concentration upon mixing with persulfate, with a subsequent
return to expected concentration over time

96

. Because these phenomena made it difficult to

measure the true initial concentration of ciprofloxacin in solution with unactivated persulfate, the
initial ciprofloxacin for all measurements was taken as the concentration of ciprofloxacin prior to
mixing with persulfate, adjusted for dilution by aqueous persulfate. Ciprofloxacin concentrations
as measured by HPLC-MS peaked at 30 minutes, so this was designated as the minimum time for
adequate mixing, after which persulfate activation using the solid iron was initiated. At higher
ciprofloxacin concentrations (0.242 mmol L-1 and 0.302 mmol L-1), a white floc-like substance
was observed to form in solution within five minutes of mixing sodium persulfate with
ciprofloxacin. This floc was pH dependent and was only observed below the third pKa (8.7) of
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ciprofloxacin96 and may be attributable to the zwitterionic characteristic of the ciprofloxacin177.
Side-by-side comparisons did not show this effect when ciprofloxacin was mixed with potassium
persulfate, potassium sulfate or sodium sulfate, which may have indicated which species
(persulfate, sulfate or sodium) was responsible for the floc. The floc dissipated immediately upon
addition of the iron rod and was not expected to affect results of this study.
Using HPLC-MS and IC analysis, it was determined that ciprofloxacin degradation began
before persulfate activation was initiated by the iron rod, as observed by formation of expected byproducts during mixing, as well as defluorination of the ciprofloxacin44, 96, 176. By-products with a
m/z of 362, 330, and 306, as listed in Table 3.11, were observed to form in solution after 5 minutes
of mixing and increase after 30 minutes of mixing. Approximately 12% defluorination was
observed during the 30 minutes of mixing. Furthermore, the ciprofloxacin concentration was
measure as 25% lower than expected based on ciprofloxacin concentration prior to mixing. A
comparison of ciprofloxacin removal before mixing (section II) and after activation (section II)
can be seen in the inset of Figure 3.6. A corresponding decrease in persulfate concentration, which
would indicate persulfate activation by ciprofloxacin, was not detected.
Ciprofloxacin degradation by activated persulfate: Upon insertion of the iron rod into the
ciprofloxacin-persulfate solution, ciprofloxacin degradation accelerated, as highlighted in section
II of the inset of Figure 3.6. Ciprofloxacin removal increased from 20% before persulfate
activation to 92% in activated persulfate after 5 minutes. Degradation plateaued at 95% removal
after 15 minutes of contact with solid iron activated persulfate. These results are comparable to
ferrous activated persulfate for ciprofloxacin degradation, which achieved 80% removal of
ciprofloxacin in the first five minutes of the study, and overall 95.6% removal with a ciprofloxacin
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Table 3.11. Primary Transformation Products
m/z

334
306
330
362
263

Time formed

*Upon activation
**Upon mixing
**Upon mixing
**Upon mixing
*Upon activation

***Time removed

Also Detected

30 minutes
30 minutes
15 minutes
15 minutes
60 minutes

96, 176, 183
96, 183, 184
44, 60, 96, 176
96
96, 183

*Upon activation indicates that this product was formed after initiation of persulfate activation by insertion of iron
rod into persulfate-ciprofloxacin mixing
*Upon mixing indicates product was formed upon 5 minutes of mixing persulfate with ciprofloxacin
***Time removed indicates the time elapsed after initiation of persulfate activation

Figure 3.6. Ciprofloxacin and ciprofloxacin/TP matrix degradation as a function of time
Initial persulfate concentration was 18 mmol L-1. Iron surface area=6.1 cm2. Error bars represent
95% interval. [Ciprofloxacin]0=0.121 mmol L-1 upon mixing with persulfate, 0.090 mmol L-1
upon initiation of persulfate activation at t=0. Inset: Ciprofloxacin degradation by persulfate.
Section I. is ciprofloxacin removal upon mixing with persulfate, with initial concentration
determined by ciprofloxacin concentration pre-mixing. Section II. is ciprofloxacin degradation
upon persulfate activation by insertion of solid iron rod.
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to persulfate to iron ratio of 1:20:20 96. Results also align with UV activated persulfate, in which
70% ciprofloxacin removal was achieved in five minutes and 98% removal overall 185. Achieving
similar removal to those established in previous studies validates solid iron as a viable method for
activating persulfate to achieve contaminant removal, a key objective of this study.
While much attention has focused on removal of primary pollutants in the environmental,
the formation and degradation of intermediates and by-products is gaining attention, as many of
these secondary components have the potential for negative environmental impact165, 186. Limited
information is available about the environmental effect of ciprofloxacin transformation products
(TPs), but some studies have found these compounds to be mutagenic and/or genotoxic to several
cell lines187, 188. Because of the potential environmental impact of both ciprofloxacin and its TPs,
the effect of solid iron activated persulfate on generating and degrading these compounds warrants
further investigation. Using HPLC-MS, this study identified the formation and removal of five
TPs with the core quinolone structure intact, as well as smaller amounts of several unidentified
TPs. These are listed in Table 3.11. Removal of the ciprofloxacin/TP matrix, as determined by
HPLC-MS, is illustrated on the “ciprofloxacin/TP matrix (HPLC-MS)” curve on Figure 3.6. The
ciprofloxacin/TP matrix undergoes removal by iron activated persulfate, albeit at a slower rate
than ciprofloxacin itself. 90% of the ciprofloxacin/TP matrix was degraded in 30 minutes, with
negligible removal after that time period. Because only partial mineralization occurred, as
discussed in section 3.2.4, it is clear that one or more transformation products remained in solution
and were not detected by the current HPLC-MS analytical methods, which is similar to the finding
by Toolaram et al. (2016) in a study of photo-transformation products of ciprofloxacin 187. It was
also noted that the ciprofloxacin/TP matrix had a strong UV/Vis absorbance at 272 nm when
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measured directly (without HPLC separation).

The presence and removal of the matrix,

determined by an examination of relative absorbance peak heights at each time point, followed a
similar trend as the presence and removal measured by HPLC-MS. This trend is demonstrated on
the “ciprofloxacin/TP matrix (UV/Vis)” curve in Figure 3.6.
According to UV/Vis analysis, 78% of the ciprofloxacin/TP matrix is degraded by iron
activated persulfate in 45 minutes, while degradation plateaued at 83%. Although the overall
removal is slightly lower than that determined by HPLC-MS, it is still higher than TOC removal
discussed in Section 3.2.4. Like the HPLC-MS data, these results indicate that one or more byproducts remain in solution undetected by the UV/Vis technique. Because UV/Vis provided
consistent results within the range of HPLC-MS and TOC analysis, it was decided that using the
UV/Vis method to compare ciprofloxacin/TP matrix removal with and without current applied to
the iron anode was appropriate for the bulk solution.
Effects of applied current on ciprofloxacin/TP matrix degradation: Figures 3.7a and 3.7b
show ciprofloxacin/TP matrix degradation by solid iron activated persulfate with and without an
applied current. A maximum current density of 11.5 mA cm-2 was tested because persulfate
activation plateaued at this level per Figure 3.3b. The ciprofloxacin/TP matrix was characterized
to degrade in a pseudo-first-order manner with respect to the matrix. Data from the 0.121 mmol
L-1 experiments without applied current resulted in a pseudo-first-order reaction rate constant, k1,cip
, of 6.58 x 10-4 s-1. This pseudo-first-order reaction rate constant was independent of current, as
discussed below and tabulated in Table 3.12. An average of 83% ciprofloxacin/TP matrix removal
was achieved across all data sets in Figure 3.7a and a total of 1.1 mmol L-1 iron was added to
solution to achieve this removal. Although most degradation reactions using persulfate are
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characterized as pseudo-first-order with respect to the analyte, the predicted higher order nature of
these reactions leads the reaction rate to vary slightly with different ratios of analyte to persulfate.
In many cases, less analyte and or more persulfate will drive the reaction more quickly or viceversa

96

. This effect is seen currently, with a pseudo-first-order reaction rate constant, k1,cip , of

4.59 x 10-4 s-1 when initial ciprofloxacin concentration is doubled to 0.242 mmol L-1.
In iron activated persulfate degradation studies of trichloroethylene and pentachlorophenol,
increasing current applied to an iron rod enhanced removal rates141, 142. In contrast, the rate and
extent of ciprofloxacin/TP matrix removal in this study was independent of applied current, as
shown by the overlapping curves in Figures 3.7a and 3.7b. Ciprofloxacin/TP matrix removal was
constant at the four current densities tested despite higher rates of persulfate decomposition as
current density increased (Figure 3.8). Increased iron introduction by the applied current, and the
resulting increased persulfate activation, may generate an overabundance of radical scavenging
ferrous ions (equation 1.13) as well as propagate self-scavenging by sulfate and
hydroxyl radicals. These effects have been noted to inhibit contaminant removal at high iron or
persulfate levels in some other studies48.
Defluorination, mineralization and degradation mechanism: Fluoride abstraction is an
important outcome in the degradation of fluorinated pharmaceuticals, as it may lower their
toxicity189. Figure 3.9a shows ciprofloxacin degradation along with fluoride generation from
ciprofloxacin. Defluorination slightly lags ciprofloxacin removal, with 75% de-fluorination
achieved in 5 minutes, as shown in Figure 3.9b. De-fluorination reached >95% after 15 minutes,
in line with the 95% ciprofloxacin removal achieved in this same time period. This degree of
fluoride removal is significantly higher than that achieved by some other ciprofloxacin degradation
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Figure 3.7. Ciprofloxacin degradation at various current densities, as a function of time
Initial persulfate concentration was 18 mmol L-1. Iron surface area=6.1 cm2. Error bars represent
95% interval. (a) [Ciprofloxacin]0=0.121 mmol L-1 (b) [Ciprofloxacin]0=0.242 mmol L-1.
Measured via UV/Vis absorbance.
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Table 3.12. Statistical Parameters for ciprofloxacin/TP matrix pseudofirst order degradation reaction rate constants
[Ciprofloxacin]o = 0.121 mmol L-1]
Current Density
Parameter
-2
(mA cm )
0.0
Value
Standard error
R2
3.3
Value
Standard error
R2
11.5
Value
Standard error
R2
MeOH Quench
Value
(no current)
Standard error
R2
TBA Quench
Value
(no current)
Standard error
R2

Slope
(s-1)
-0.000658
0.000111
0.9220
-0.000653
0.000136
0.9199
-0.000628
0.000104
0.9244
-0.000115
2.0E-05
0.9138
-0.000151
1.3E-05
0.9861

Intercept
(LN (C/Co cipro)
-0.2129
0.167

[Ciprofloxacin]o = 0.242 mmol L-1]
Current Density
Parameter
(mA cm-2)
0.0
Value
Standard error
R2
11.5
Value
Standard error
R2

Slope
(s-1)
-0.000460
3.29E-05
0.9848
-0.000487
4.09E-05
0.9726

Intercept
(LN (C/Co cipro)
-0.116
0.0621

-0.18451
0.199
-0.202
0.157
0.0608
0.062
0.0380
0.024

-0.0293
0.0836
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Figure 3.8. Persulfate decomposition rate with and without ciprofloxacin
Shown for three different current densities. [Ciprofloxacin]0= 0.121 mmol L-1 [Persulfate]0=18
mmol L-1 . Iron surface area=6.1 cm2. Quinoline degradation intermediates are suggested to
enhance persulfate activation.
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Figure 3.9. Fluoride generation and TOC removal as a function of time
(a) Ciprofloxacin degradation and fluoride generation from ciprofloxacin as a function of time.
(b) Comparison of relative degrees of ciprofloxacin or TOC removal and fluoride generation as a
function of time. Initial ciprofloxacin and persulfate concentrations were 0.121 mmol L-1 and 18
mmol L-1, respectively . Iron surface area=6.1 cm2. Error bars represent 95% interval.
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studies indicating that solid iron activated persulfate may offer an advantage for removal of some
fluorinated compounds176, 183.
As mention previously, TPs with m/z of 362, 330, and 306 formed upon mixing of
ciprofloxacin with persulfate. Additionally, upon activation of persulfate, compounds with m/z of
334 and 263 were detected, as outlined in supplementary table 3.11. The presence of these TPs
corresponds with degradation pathways of piperazine ring cleavage and substitution described in
other studies 96, 176. The compound with m/z 330, where fluoride is replaced by a hydroxyl radical,
was detected at high levels upon mixing, as well as in the initial 15 minutes of the reaction, which
corresponds with the quick de-fluorination observed in the first 15 minutes. Based on these
findings, substitution is suggested as the primary degradation mechanism for ciprofloxacin
removal by solid iron activated persulfate. At the end of 60 minutes, the five primary TPs named
in this study were non-detectable in solution, and only unidentified compounds remained.
Total organic carbon (TOC) removal is shown in Figure 3.9b. At the end of 60 minutes,
an average of 44% TOC was removed from solution, afterwards which removal plateaued.
Incomplete mineralization was achieved with this process and follow-up studies are recommended
to identify the presence and hazards of compounds remaining in solution.
Quenching studies to determine dominant radicals: The relative contribution of the sulfate
and hydroxyl radicals to ciprofloxacin degradation was studied using radical quenchers methanol
and tert-butanol (TBA). Methanol has high reaction rates with both radicals, with a reaction rate
constant of 1.0 x 107 M-1 s-1 for the sulfate radical and 9.7 x 108 M-1 s-1 for the hydroxyl radical 42.
TBA has a slower reaction rate with the sulfate radical, with a rate constant of (4.0-9.1) x 105 M-1
s-1 for the sulfate radical versus a reaction rate constant of (3.8-7.6) x108 M-1 s-1 with the hydroxyl
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radical 42. The ciprofloxacin pseudo-first order reaction rate constants with and without quenching
are illustrated in Figure 3.10.

With TBA preferentially quenching hydroxyl radicals, the

ciprofloxacin rate constant decreased by 77.1% (from 6.58 to 1.51 x 10-4 s-1), indicating that
hydroxyl radicals play a substantial role in the degradation process. With methanol quenching
both hydroxyl and sulfate radicals, the ciprofloxacin rate constant only decreased another 5.4% to
a value of 1.15 x 10-4 s-1, suggesting that sulfate radicals play a far less significant role in the
degradation mechanism than hydroxyl radicals. Some studies suggest that the hydroxyl radical is
the dominant reactive species in iron-activated persulfate systems, even at acidic pH, and the
current findings supports this conclusion141, 190. This hydroxyl dominated process may explain the
primary degradation pathway of fluoride substitution by hydroxyl species noted in section 3.2.4.
As noted by Yuan et al. (2014) during quenching studies of trichloroethylene degradation with
iron activated persulfate, the degradation reaction was not completely quenched by the radical
scavengers, which implies that other reactive species may be involved in the degradation
mechanism

141

. Hydrogen peroxide, theoretically present in solution, was not detectable in this

study.
Persulfate usage during ciprofloxacin degradation: Of note is the enhanced persulfate
decomposition with ciprofloxacin in solution (Figure 3.8). Fang et al. (2013) demonstrated
persulfate activation by quinones and compounds containing quinone structures such as
ciprofloxacin51.

Control experiments in this study did not show persulfate activation by

ciprofloxacin directly, so it is theorized that, in this case, a quinone degradation intermediates
enhanced the reaction. This may have broad implication for activated persulfate degradation of
ciprofloxacin using other persulfate activators.
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Figure 3.10. Ciprofloxacin/TP matrix pseudo-first order rate constants with quenching.
Initial ciprofloxacin and persulfate concentrations were 0.121 mmol L-1 and 18 mmol L-1,
respectively . Iron surface area=6.1 cm2. Concentration of methanol and TBA quenchers was 220
mmol L-1. Measured by UV/Vis.

The reaction stoichiometric ratio (RSE) can be used to compare degradation results for
different analytes and between activation techniques. It is defined as the number of moles of
analyte removed divided by the number of moles of persulfate consumed, reported as a percentage
166

. The RSE for the ciprofloxacin/TP matrix for experiments without current (Figure 3.7a) was

7.7% at 30 minutes and 5.6% at 60 minutes. In comparison, the RSE for ibuprofen degradation by
heat activated persulfate was 7.5% and the RSE for sulfamethoxazole removal by Fe0 activated
persulfate was 6.0%, both measured at 60 minutes95,

165

. For sulfamethoxazole removal by

micrometric Fe0 activated persulfate, the RSE was 3.7% in 60 minutes102. The similar scale of
pharmaceutical to persulfate ratios achieved across studies may provide guidance or expectations
for future work in this area. For experiments in this study conducted with 8.2 mA cm -2 applied
current, (Figure 3.7a), the RSE for the ciprofloxacin/TP matrix was 3.5% at 30 minutes and 1.0%
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at 60 minutes. The lower RSE with applied current was a result of similar ciprofloxacin/TP matrix
degradation with higher persulfate activation when current was applied.
3.4 Conclusion
Persulfate activation by solid iron is proposed to be a surface dominated mechanism. The
fundamental relationships between iron surface area, applied current, iron production and
persulfate activation were elucidated by experimentation without analyte in solution. Sustained
persulfate activation can be accomplished with the use of solid iron, with 1.14 moles of persulfate
activated for 1 mole of iron used. The surface area of the solid iron can be adjusted to control the
persulfate activation rate.

Applied current enhances persulfate activation until diffusion

limitations are reached. Ciprofloxacin was degraded by solid iron activated persulfate, with 95%
removal achieved in 15 minutes under experimental conditions. Furthermore, the corresponding
transformation product matrix was also removed by 90% in 30 minutes by solid iron activated
persulfate process. The ciprofloxacin/transformation product matrix degrades via a pseudo-first
order mechanism with respect to the matrix, with hydroxyl radicals identified as the primary
reactive species. Defluorination under the same conditions was >95%, demonstrating that solid
iron activated persulfate may offer an advantageous technique for removal of fluorinated
environmental contaminants. Enhancement of the ciprofloxacin degradation was not achieved by
applying a current to the iron electrode despite increased persulfate activation. This is possibly
due to the scavenging effect of excess ferrous ions and radical species.
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CHAPTER FOUR: UNDERSTANDING ELECTROCHEMICALLY ACTIVATED
PERSULFATE AND ITS APPLICATION TO CIPROFLOXACIN ABATEMENT
This chapter is revised based on a paper published as follows:
Matzek, L.W., Tipton, M.J., Farmer, A.T., Steen, A., Carter, K.E., 2018. Understanding
Electrochemically Activated Persulfate and Its Application to Ciprofloxacin Abatement. Environ
Sci Technology.
4.1 Introduction
Electrochemically activated persulfate (EAP) analyte removal has not been widely addressed
except in cases where iron is a co-activator48, 191. EAP without an iron co-activator avoids the use
of a sacrificial anode and the introduction of iron in systems where this would not be suitable.
Studies investigating EAP without iron suggest persulfate activation, through direct electron
transfer at the cathode, creates sulfate radicals (Equation 2.3)59, 133.
Recent studies found persulfate addition to electrochemical abatement of industrial
wastewater improved removal of dinitrotoluene and aniline but did not compare the effects created
by sulfate addition59,

133

.

Another report indicated persulfate addition to sodium chloride

electrolyte increased COD removal for malachite green and 2,4-dinitrophenol while sulfate did
not, though differences between these electrolytes was not the focus192. Farhat et al. (2015) found
that persulfate addition to nitrate electrolyte did not result in as fast of a diatrizoate removal rate
as in pure sulfate42. However, equimolar amounts of persulfate and sulfate were not compared,
and cathodic persulfate activation was not explored42.
Other studies have examined the role of sulfate radicals (Eo = 2.5-3.1 V) in EAOP42, 193.
Sulfate radicals form anodically using BDD electrodes (Equation 4.1) and will degrade many
organic analytes42, 48. These radicals can also form reactive hydroxyl radicals (Equation 4.1) 48.
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Higher removal rates for diatrizoate and carbamazepine were achieved in sulfate versus nitrate
electrolyte, which was credited to anodic sulfate radical formation42, 193.
(4.1)

∙−
−
SO2−
4 → SO4 + e

The purpose of this study is to explore/characterize/quantify enhanced electrochemical
removal of organic species observed in sulfate and persulfate electrolytes, including the roles
played by sulfate radical formation at the anode and persulfate activation at the cathode.133, 192
Elucidating the sources and roles reactive species play in sulfate radical-based systems lends
insight to appropriate application and design of electrochemical abatement systems. Finally,
although fluoroquinolone removal has previously been demonstrated at a boron-doped diamond
(BDD) anode in synthetic urine and a SnO2/Sb-Ti anode in sodium sulfate, it has not been
evaluated in the EAP system44, 194. Thus, this study aims to assess EAP’s ability to remove
ciprofloxacin and investigate removal mechanisms as a step in screening EAP as an appropriate
point source treatment for wastewaters with high antibiotic content22, 44.
4.2 Materials and Methods
4.2.1 Chemicals
Ciprofloxacin (98%), sodium persulfate (98%), potassium sulfate, sodium nitrate, potassium
iodide (99+%), sodium bicarbonate (Acros Organic, Fair Lawn, NJ), Optima formic acid, sodium
hydroxide, hydrochloric acid, Optima Methanol (MeOH), tert-butanol (TBA), dimethyl sulfoxide
(DMSO), and fluoride standard were purchased from Fisher Scientific (Pittsburg, PA) and 1N
sulfuric acid was from J.T. Baker. Deionized water (DI) (18.2 MΩ-cm) was produced by a
Millipore Milli-Q system.
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4.2.2 Experimental Setup
Rotating disk electrode (RDE) experiments were performed using a SP-150 potentiostat (BioLogic Science Instruments, Knoxville, TN) with a mercury-mercury sulfate reference electrode in
single-cell or split-cell configuration, illustrated by Figures 4.1a and 4.1b. A multi-speed rotator
(Pine Research Instrumentation, PRI, Durham, NC) was set to 2000 rpm for RDE experiments
with bulk mixing with a magnetic stir-bar. Anodes (0.5 cm O.D., 0.196 cm -2 surface area) were a
change-disk RDE tip (PRI) with BDD electrode insert (Fraunhofer Center for Coatings and
Diamond Technologies, East Lansing, MI), or fixed-disk platinum (Pt) RDE tip (PRI). The
potential window for the BDD was -1.2V to 2.5V vs. SHE. Cathodes were Electron Microscopy
Science graphite (Gr) rods (0.30 cm O.D) (Fisher Scientific, Pittsburg, PA), or a platinum wire
(0.5 mm O.D.) (PRI). Cathodic surface areas exposed to solution were 4.8 cm2 for graphite and
3.69-4.76 cm2 for Pt. Potential windows for cathode materials are -1.5 to 1.5 V (Gr) and -0.85 to
1.9 V (Pt) 195.
For single-cell persulfate experiments, 200 mL of 22 mmol L-1 persulfate was electrolyzed
and sampled periodically. Single-cell ciprofloxacin experiments used 50 mL of 0.171 mmol L-1
ciprofloxacin (0.1% sulfuric acid to aid dissolution) mixed with 140 mL DI water. The solution
was spiked with 10 mL concentrated electrolyte just before applying constant anodic current
density of 76 mA cm-2, unless noted otherwise. Initial concentrations were 0.043 mmol L-1
ciprofloxacin plus 22 mmol L-1 sulfate or persulfate, or 66 mmol L-1 nitrate, maintaining the same
ionic strength for all solutions. Quenching experiments were performed by replacing some water
with TBA or DMSO to achieve quencher concentration of 2200 mmol L-1, which provided 100:1
a quencher to persulfate ratio158, 185.
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Split-cell experiments were performed using 300-mL anodic and 80-mL cathodic
compartments. Reaction times were normalized to a 200-mL volume per Equation 4.2.
(4.2)

reaction timenormalized = timereaction x

normalzied volume
reactor volume

A cation-exchange Chemours 115 Nafion membrane (Fuel Cell Store, College Station,
TX), separated the compartments and was experimentally confirmed not to transmit
nitrate/sulfate/persulfate anions. Current density of 28.5 mA cm-2 was employed due to system
physical limitations. For ciprofloxacin removal, outcomes are indicative of behavior in the singlecell reactor, but numerical results are not directly comparable due to current densities utilized.
Experiments were performed in duplicate at 20˚C. Initial pHs averaged 4.5 upon mixing
ciprofloxacin and electrolytes. Average final pHs were 2.5, 6.5, and 8.0 in persulfate, sulfate, and
nitrate, respectively. pH was not controlled in any experiments as buffer anions can significantly
alter the system chemistry confounding interpretation of the results104, 135, 141, 177, 196, 197. As the pH
range impacts the kinetics of electrochemical degradation reactions by influencing the active
radical species involved (hydroxyl or sulfate)48, this study aims to understand the natural
progression of these reactions, including the possibility that different reaction kinetics may occur
due to pH shifts from different species formed in the three electrolytes.
4.2.3 Analytical Methods
Persulfate and ciprofloxacin-matrix concentrations were analyzed using a ThermoScientific
Evolution 600 UV/Vis spectrometer (ThermoFisher, Pittsburg, PA) at 272 and 352 nm,
respectively, with methodology described in Chapter 3180, 181, 191.
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Figure 4.1a. Single-cell reactor with rotating disk electrode (RDE)
Total volume = 200 mL.

Figure 4.1b. Split-cell reactor with rotating disk electrode (RDE)
Anode Volume = 300 mL. Cathode volume = 80 mL.
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In Chapter 3, it was shown that the “ciprofloxacin-matrix” concentrations measured by
UV/Vis without HPLC separation were proportional to the total concentration determined by
HPLC-MS analysis of a mixture containing ciprofloxacin and its transformation byproducts, which
includes core quinolone structures with potentially negative environmental effects187, 188, 191. This
matrix’s UV/Vis absorbance is attributed to ciprofloxacin and its transformation products
containing the C=C-C=C-C=C-C=0 chromophore198. While ciprofloxacin-matrix concentration
does not account for every degradation by-product that may be generated, it is a consistently
reproducible and easily modeled variable found to be proportional to actual ciprofloxacin and TOC
concentrations. Because of its repeatability, proportionate relationship to TOC, and inclusion of
significant by-products, the ciprofloxacin-matrix concentration is utilized in this study to compare
results between experimental runs.
Waters Sep-Pak tC2 cartridges were used to extract ciprofloxacin for HPLC-UV and
HPLC-MS analysis. Cartridges were conditioned with 1 mL methanol then 1mL DI water. A 0.5mL sample was loaded then extracted using 2X1-mL quantities of methanol/0.1% formic acid.191
The extraction efficiency was 80%, measured by comparing extracted standards to standards made
in methanol/0.1% formic acid.
Extracted ciprofloxacin was quantified by separation using a Shimadzu HPLC equipped
with binary pumps, a Hypersil Gold column (100 mm × 4.6 mm I.D. , 5 µm

diameter)

(Thermoscientific, Waltham, MA) and a SPD-M20A diode array detector. A gradient eluent
separation was used with eluent “A” DI water/0.1% formic acid and eluent “B” acetonitrile/0.1%
formic acid. A multi-step gradient program varied from 5% - 95% eluent A over 20 minutes (Table
4.1). Column temperature was held at 40˚C. Sample absorbance was measured at 278 nm, which
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was confirmed to be the absorbance maximum of ciprofloxacin standards. Statistics for the
calibration curve are provided in Table 4.2. The instrument detection limit was 0.30 µmol L-1 and
method detection limit was 0.38 µmol L-1.

Table 4.1. HPLC-UV Multi-step Gradient Program
Time (min)
0
2
8
12
14
16
19
20

%A
5
5
75
75
95
95
5
5

Table 4.2. Statistical Parameters for HPLC-UV

Value
Standard error
R2

Slope
(peak area per µmol L-1)
14004
211
0.9993

Intercept
(peak area)
-12353
4835

Extracted samples were diluted with methanol and analyzed for intermediates and
transformation by-products using a Thermo Scientific Exactive™ Plus Orbitrap LC-MS with
ultimate 3000 RS pump, column compartment, autosampler, and diode array detector
(ThermoFisher, Pittsburgh, PA). The mobile phase consisted of 80/20 methanol/water with flow
rate 0.2mL min-1, 10-minute run time, and 10-µL sample injection. UV/Vis was used to detect the
antibiotic and byproduct species at 275 nm and 3D field from 200-400nm199. A mass to charge
(m/z) scan range of 50-500 m/z with resolution of 140,000 was performed using positive mode
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electrospray ionization and data was analyzed to determine masses of both the parent compounds
and the degradation/transformation byproducts199-201.
TOC was analyzed using a Shimadzu TOC-L analyzer with an ASI-L autosampler.
Samples were diluted 1:4 with acidified DI water (pH 3.0 with HCl). Statistical parameters for the
method were described in Chapter 3191.
Hydrogen peroxide concentrations were determined by reacting equal volumes of sample
with ammonium metavanadate. The metavanadate solution was prepared with 1-part ammonium
metavanadate in 9.5 parts 1N sulfuric acid at 50˚C, then diluted with DI water to a final
concentration of 12 mM and 114 mM, respectively.
Evolution 600 UV-Vis (wavelength 450 nm)

42, 202

Absorbance was measured using the

. Absorbance was compared to solutions of

known hydrogen peroxide concentrations.
Ion chromatography used to analyze fluoride (F-) concentrations using a Dionex 2100/1100
dual column system with background suppression. pH of all samples was raised to 6, dissociating
any potential hydrofluoric acid. Fluoride detection limit was less than 5.2 µmol L-1 F- ions as
described in Chapter 3.
4.3 Results and Discussion
4.3.1 Electrochemical persulfate decomposition and regeneration
Persulfate behavior was investigated without an analyte using a single-cell RDE system for three
anode/cathode combinations: Pt/Gr, BDD/Gr and BDD/Pt. The persulfate removal rate was
measured to demonstrate the maximum potential persulfate activation rate based on equation 1.3.
For persulfate formation at the anode, this removal rate becomes the net rate of persulfate reduction
(or activation) at the cathode and persulfate generation at the anode (Equation 4.3). Similar results
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were obtained for all electrode combinations with R2>0.95 linear relationship of persulfate
decomposition with time. Plots for BDD/Gr (Figure 4.2a) illustrate these findings. The zero-order
mechanism indicates a surface-dominated reaction with the net persulfate reaction rate a function
of current density (Figure 4.3a and 4.3b). Persulfate reaction rates were independent of anode
material but were higher using a Gr-cathode compared to a Pt-cathode, as shown in Figures 4.3a
and b. Additional experiments investigating the effects of cathode material for ciprofloxacin
removal using EAP are described in Ciprofloxacin Degradation section.
To further explore the role of sulfate radicals in EAOP, electrochemical persulfate removal
and generation were examined using split-cell RDE experiments with a BDD/Gr anode/cathode
combination. Anodic persulfate generation from sulfate, shown to be a zero-order mechanism in
Figure 4.2c, was used to demonstrate the presence of sulfate radicals, as sulfate-radical based
reactions (Equation 4.3) have been shown to be the dominant mechanism of persulfate production
at BDD anodes.203
∙−
2−
(4.3) SO∙−
4 + SO4 → S2 O8

During this process, persulfate becomes available in sulfate solution to initiate non-radical
degradation or degradation through persulfate activation at the cathode42, 133, 203. As expected, no
persulfate was formed in the sulfate solution from cathodic reactions (Figure 4.2c) and no
hydrogen peroxide was detected in any of the solutions. Further evaluation of H2O2 suggests that
reaction potentials used were outside the ideal range for H2O2 formation204. As the solution was
not oxygenated, which aids H2O2 production (Equation 4.4)204, this species was determined to have
no significant influence in the current EAP system204.
(4.4) O2 + 2H + + 2e− → H2 O2
68

Figure 4.2b shows the persulfate concentration remained constant at the anode, thus
persulfate activation by anodically generated hydroxyl radicals was ruled out.

Persulfate

decomposition at the cathode followed a zero-order mechanism. The zero-order persulfate
reaction rate constant of 1.85 x 10-7 mol L-1 s-1 at a cathodic current density of 1.2 mA cm-2
corresponds to the potential sulfate radical formation rate. When the anodic persulfate formation
rate of 3.40 x 10-9 mol L-1 s-1 was subtracted from the cathodic persulfate decomposition rate, the
net reaction rate change in the divided cell was 1.82 x 10-7 mol L-1 s-1, higher than the 1.5 x 10-7
mol L-1 s-1 predicted by the single-cell curve in Figures 4.3a and b at the same current densities
(28.5/1.2 mA cm-2 anode/cathode, respectively). Differences in single-cell and split-cell reaction
rate constants imply the persulfate activation and generation processes may be dependent on one
another and are influenced by reactions occurring at the opposite electrode.

Experiments

determining whether cathodic persulfate decomposition corresponds to sulfate radical formation
at the cathode are discussed in Cyclic voltammetry and Using ciprofloxacin to evaluate persulfate
activation sections.
4.3.2 Ciprofloxacin Degradation
Removal of ciprofloxacin (extracted and separated by HPLC), ciprofloxacin-matrix (measured by
UV-Vis; see Analytical Methods) and TOC was compared for BDD/Pt and BDD/Gr electrode pairs
in a single-cell RDE system to establish how cathode materials affect EAP during analyte removal.
The pseudo-first order rate constants (and relevant statistics) for the ciprofloxacin, ciprofloxacinmatrix and TOC removal (with respect to these variables) by cathode type are shown in Tables
4.3a, b and c.
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Figure 4.2. Persulfate concentration with time in an electrochemical reactor
(a) Zero-order persulfate removal over time in a single-cell reactor with [Persulfate]0= 22 mmol
L-1. Legend values denote anodic / cathodic current densities. (b) Persulfate concentration versus
time with [Persulfate]0= 22 mmol L-1 in a split cell reactor. Anodic current density =28.5 mA cm2
and cathodic current density = 1.2 mA cm-2. (c) Persulfate concentration versus time with
[Sulfate]0 =22 mmol L-1 in a split cell reactor. Anodic current density =28.5 mA cm-2 and cathodic
current density = 1.2 mA cm-2. (a-c) BDD/Gr anode/cathode pairs. No organic analyte. Error bars
represent the 95% interval.
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Figure 4.3. Persulfate reaction rate as a function of current density
(a) Persulfate zero-order reaction rate constant as a function of anodic current density. (b)
Persulfate zero-order reaction rate constant as a function of cathodic current density. Error bars
represent the 95% interval.

71

Table 4.3a. Effects of Cathodes on Removal Rates of Ciprofloxacin
Electrolyte

Persulfate

Cathode

Pt
Gr

Ciprofloxacin
pseudo-first
order
rate
constant
(s-1 x 10-5)
1.92 ± 0.21
2.08 ± 0.58

Pseudo-first
order fit
(r2)

Difference
(%)

Statistical
significance
difference

0.9907
0.9112

8%

0.5902
(not significant)

Table 4.3b. Effects of Cathodes on Removal Rates of Ciprofloxacin-Matrix
Electrolyte

Cathode

Pseudo-first
order fit
(r2)

Difference
(%)

Statistical
significance of
difference

Pt
Gr

Ciprofloxacin
pseudo-first
order
rate
constant
(s-1 x 10-5)
4.52 ± 0.22
4.28 ± 0.18

Persulfate

0.9954
0.9907

5%

0.5769
(not significant)

Sulfate

Pt
Gr

2.28 ± 0.22
2.31 ± 0.09

0.9849
0.9892

4%

0.6663
(not significant)

Nitrate

Pt
Gr

0.54 ± 0.16
0.44 ± 0.12

0.7624
0.7691

19%

0.3029
(not significant)

Table 4.3c. Effects of Cathodes on Removal Rates of TOC
Electrolyte

Cathode

Pseudo-first
order fit
(r2)

Difference
(%)

Statistical
significance of
difference

Pt
Gr

TOC
pseudo-first
order
rate
constant
(s-1 x 10-5)
0.86 ± 0.21
0.81 ± 0.24

Persulfate

0.9465
0.9270

6%

0.6735
(not significant)

Sulfate

Pt
Gr

0.42 ± 0.13
0.44 ± 0.17

0.8723
0.9047

-5%

0.7871
(not significant)

Nitrate

Pt
Gr

0.099 ± 0.34
0.025 ± 0.28

0.0787
0.0059

75%

0.6930
(not significant)
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Differences in ciprofloxacin, ciprofloxacin-matrix and TOC degradation rates were
statistically insignificant with Pt- and Gr-cathodes. It was concluded that graphite is a suitable
substitute for platinum for ciprofloxacin removal using EAP.
Electrolyte effects on ciprofloxacin, ciprofloxacin-matrix and TOC removal were
compared using the single-cell RDE with nitrate, sulfate or persulfate. The ciprofloxacin decay
mechanism was pseudo-first order with respect to ciprofloxacin in all electrolytes, as shown in
Figures 4.4 and 4.5a. The pseudo-first order rate constants (and relevant statistics) for are shown
in Table 4.4. Ciprofloxacin degraded rapidly upon electrolysis in persulfate (Figures 4.4), reaching
84% of the initial concentration after 120 minutes and plateauing at 90% after 240 minutes. The
removal rate in sulfate was 33% slower, although similar degrees of removal were achieved within
240 minutes. Much slower removal was observed in nitrate, reaching 90% in 24 hours (Figure
4.5a). A sixfold increase in the overall reaction rate constant was observed using sulfate in place
of nitrate electrolyte. This is similar to Radjenovic et al. (2016) findings where using sulfate
instead of nitrate electrolyte resulted in a sevenfold increase in reaction rates for iopromide and
diatrizoate removal.193
Ciprofloxacin-matrix removal is shown in Figure 4.5b, with pseudo-first order modeling
with respect to the matrix illustrated in Figure 4.6. The initial stages of removal are shown in
Figure 4.7. The overall pseudo-first order rate constants (and relevant statistics) for are in Table
4.5a. Rate-constants for each electrode pairs (BDD/Pt and BDD/Gr) are also shown. A fourfold
increase in the overall reaction rate constant was observed using sulfate in place of nitrate
electrolyte. The current findings for ciprofloxacin and the ciprofloxacin-matrix, in conjunction
with the previously described persulfate experiments, confirm that sulfate does not act as an inert
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Figure 4.4. Removal of ciprofloxacin with time
(a) Removal of ciprofloxacin versus time, as measured by HPLC-UV. [Persulfate]0 or [Sulfate]0 =
22 mmol L-1. [Nitrate]0 = 66 mmol L-1. [Ciprofloxacin]0 = 0.043 mmol L-1. Experiments
completed in a single-cell RDE reactor at 76 mA cm-2 anodic current density,

Table 4.4. Effects of Electrolytes on Removal Rates of Ciprofloxacin
Analyte

Electrolyte Ciprofloxacin Pseudo- Rate
Pseudo-first first
Constant
order
rate order fit Difference
constant
(R2)
from
-1
-4
(s x 10 )
Persulfate
(%)

Ciprofloxacin persulfate

Statistical
Significance of
Difference from
Persulfate

2.08 ± 0.58

0.9112

sulfate

1.39 ± 0.14

0.9717

33%

>99%(p<0.0039)

nitrate

0.24 ± 0.05

0.9517

88%

>99%(p<0.0001)

± denotes 95% confidence intervals
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Figure 4.5. Removal of ciprofloxacin with time
(a) Removal of ciprofloxacin versus time, as measured by HPLC-UV. (b) Removal of
ciprofloxacin-matrix versus time, as measured on UV/Vis (c) Total organic carbon removal versus
time (d) Total organic carbon removal from ciprofloxacin after 24 hours. [Persulfate]0 or [Sulfate]0
= 22 mmol L-1. [Nitrate]0 = 66 mmol L-1. [Ciprofloxacin]0 = 0.043 mmol L-1. Experiments
completed in a single-cell RDE reactor at 76 mA cm-2 anodic current density and 1.33 mA cm-2
cathodic current density. BDD anode, data included for Gr or Pt cathodes.
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Figure 4.6. Pseudo-first order kinetics for degradation of ciprofloxacin-matrix
Data from Figure 4.5b. Single-cell RDE, BDD anode with graphite or platinum cathode. Anodic
current density = 76 mA cm-2 and cathodic current density = 1.33 mA cm-2. [Persulfate]0 = 22
mmol L-1 OR [Sulfate]0 = 22 mmol L-1 OR [Nitrate]0 = 66 mmol L-1.
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Figure 4.7. Initial stages of ciprofloxacin removal
Data from Figure 4.5. (a) Removal of ciprofloxacin matrix versus time, as measured on UV/Vis
(b) Total organic carbon removal versus time. [Persulfate]0 or [Sulfate]0 = 22 mmol L-1. [Nitrate]0
= 66 mmol L-1. [Ciprofloxacin]0 = 0.043 mmol L-1. Experiments completed in a single-cell RDE
reactor at 76 mA cm-2 anodic current density and 1.33 mA cm-2 cathodic current density. BDD
anode, data included for Gr or Pt cathodes.
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Table 4.5a. Effects of Electrolytes on Removal Rates of Ciprofloxacin Matrix
Electrode
Combination

Electrolyte

BDD-Pt

persulfate

4.52 ± 0.22

0.9954

sulfate

2.31 ± 0.09

0.9892

49%

>99% (p<0.0001)

nitrate

0.54 ± 0.16

0.7624

88%

>99% (p<0.0001)

persulfate

4.28 ± 0.18

0.9907

sulfate

2.28 ± 0.22

0.9849

47%

>99% (p<0.0001)

nitrate

0.44 ± 0.12

0.7691

90%

>99% (p<0.0001)

persulfate

4.33 ± 0.14

0.9891

sulfate

2.29 ± 0.08

0.9823

47%

>99%(p<0.0001)

nitrate

0.48 ± 0.09

0.7530

91%

>99%(p<0.0001)

BDD-Gr

Overall

Ciprofloxacin
Ciprofloxacin Rate Constant Statistical
pseudo-first
pseudo-first Difference from Significance
order
rate order fit
Persulfate (%) Difference
constant
(R2)
(s-1 x 10-5)
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Table 4.5b. Effects of Electrolytes on Removal Rates of TOC from Ciprofloxacin Matrix
Electrode
Combination

Electrolyte

BDD-Pt

persulfate

0.86 ± 0.21

0.9465

sulfate

0.42 ± 0.13

0.8723

51%

>99% (p=0.0008)

nitrate

0.099 ± 0.34

0.0787

88%

>99% (p<0.0001)

persulfate

0.81 ± 0.24

0.9270

sulfate

0.44 ± 0.17

0.9047

46%

> 99% (p=0.0091)

nitrate

0.025 ± 0.28

0.0059

97%

>99% (p<0.0001)

persulfate

0.83 ± 0.13

0.9396

sulfate

0.43 ± 0.10

0.8582

48%

>99% (p<0.0001)

nitrate

0.061 ± 0.18

0.317

93%

>99% (p<0.0001)

BDD-Gr

Overall

TOC
Pseudo-first
pseudo-first
order fit
order
rate (R2)
constant
(s-1 x 10-5)

± denotes 95% confidence intervals
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Rate Constant Statistical
Difference from Significance
Persulfate (%) Difference
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electrolyte when using BDD anodes, rather it participates in degradation reactions, likely through
sulfate radical formation. A significant increase of 47% was achieved for the ciprofloxacin-matrix
reaction rate constant using persulfate instead of sulfate electrolyte, which may be attributed to
cathodic persulfate activation, as described in Cyclic voltammetry and Using ciprofloxacin to
evaluate persulfate activation sections.

While the matrix removal reached ~85% for both

persulfate and sulfate, persulfate attained this removal in ~12 hours versus ~24 hours for sulfate.
TOC removal followed pseudo-first order kinetics in sulfate and persulfate (Figure 4.5c,
Table 4.5b), with respect to TOC concentration. Results by cathode type are provided in Table
4.3b. Degradation was proportional to but less than ciprofloxacin-matrix removal. Although the
pseudo-first order fit for nitrate was poor, this model aided quantitative comparison. Nitrate
initially produced more rapid TOC degradation than sulfate or persulfate electrolytes, and similar
removal was observed for sulfate and persulfate during this initial timeframe (Figure 4.7).
However, TOC removal in nitrate quickly plateaued and little removal was observed after the twohour mark, while persulfate began to show better removal than sulfate. The effect of sulfate over
nitrate produced a sevenfold increase in TOC removal rate (p<0.0001). For the time series, the
additional TOC removal rate for persulfate versus sulfate was 48%, slightly larger than that
observed for the ciprofloxacin relationship (Table 4.4) and similar to that for the ciprofloxacinmatrix relationship (Table 4.5b). Comparison of 24-hour removal rates is shown in Figure 4.5d.
For both environmentally relevant parameters, ciprofloxacin and TOC removal, EAP offers an
advantage for degradation and may be the best approach for some EAOP applications.
Figure 4.8 shows the specific energy consumption for the data in Figure 4.5. Energy
consumption per unit mass of TOC removed was calculated using Equation 4.5 and presented in
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Figure 4.8. Removal of ciprofloxacin versus specific electrical charge
(a) Removal of ciprofloxacin versus specific electrical charge, as measured by HPLC-MS. (b)
Removal of ciprofloxacin matrix versus specific electrical charge, as measured on UV/Vis. (c)
Removal of TOC versus specific electrical charge. [Persulfate]0 or [Sulfate]0 = 22 mmol L-1.
[Nitrate]0 = 66 mmol L-1. [Ciprofloxacin]0 = 0.043 mmol L-1. Experiments completed in a singlecell RDE reactor at 76 mA cm-2 anodic current density and 1.33 mA cm-2 cathodic current density.
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Table 4.6.
(4.5)

Energy consumption (EC) per unit mass205 (kWh (g )-1) =

Ecell ∗ I ∗ t
𝑉∗([𝐴]−[𝐴]0 )

For Equation 4.5, Ecell = average cell voltage, I = current, V = cell volume, t= time and A= TOC
concentration, OR ciprofloxacin matrix concentration. Energy consumption for persulfate and
sulfate electrolytes was in line with that determined for electro-Fenton degradation of enrofloxacin
using a BDD anode205.
Faraday’s law was used to calculate the Coulombic efficiency for ciprofloxacin removal in
all three electrolytes. From Figure 4.4, 120 minutes was used as the timepoint to calculate
coulombs based on a constant 15 mA current. Faraday’s law establishes that 1.12 mmoles of
ciprofloxacin should be degraded under theoretical 100% current efficiency. In nitrate, 0.013
mmoles were degraded, giving a 1.2% coulombic efficiency. In sulfate, 0.029 mmoles
ciprofloxacin were degraded, giving a 2.6% efficiency. In persulfate, 0.034 mmoles were
degraded, giving a 3.1% efficiency.

Table 4.6. Energy consumption during removal of TOC from Ciprofloxacin
Analyte

TOC

Electrolyte

TOC
PseudoPseudo-first first
order
rate order fit
constant
(R2)
-1
-5
(s x 10 )

persulfate

0.83 ± 0.13

0.9396

sulfate
nitrate

0.43 ± 0.10
0.061 ± 0.18

0.8582
0.317

Rate
Constant
Difference
from Persulfate

Energy
Consumption
Unit Mass
(kWh (g -1))

per

0.428
48%
93%

0.578
1.60

± denotes 95% confidence intervals

Persulfate was measured during ciprofloxacin reactions in both sulfate and persulfate
electrolytes (Figure 4.9). Ultimately, persulfate reduced to sulfate (Figure 4.10), with 1.99 moles
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sulfate formed for every mole persulfate decomposed. In ciprofloxacin-persulfate solutions,
persulfate did not follow the same kinetics as in experiments without organic analyte. Persulfate
decayed following a pseudo-first order mechanism with respect to persulfate with R2=0.99 (Figure
4.9). The pseudo-first order kinetics indicates that, in addition to surface-based persulfate
decomposition and generation, there are bulk persulfate reactions that depend on the persulfate
concentration, which include possible interactions between persulfate and ciprofloxacin or
persulfate and organic radicals.

In fact, although both ciprofloxacin decay and persulfate

decomposition model well as pseudo-first order mechanisms with respect to themselves, (the
typical kinetic model used in environmental remediation studies48), there is a second-order
relationship at play between the persulfate and ciprofloxacin-matrix, shown in Figure 4.11. The
second-order reaction rate constant, calculated by Equation 4.6, is 2.1 x 10-2 L mol-1 s-1 with
R2=0.95206, indicating a slow reaction rate between persulfate and the ciprofloxacin206.
(4.6)

Second-order kinetics model206
ln

[𝐴]0 [𝐵]
= ([𝐵]0 − [𝐴]0 ) 𝑘 𝑡
[𝐴] [𝐵]0

In Equation 4.6, [A]= [Ciprofloxacin] and [A]0 = 0.043 mmol L-1, [B] = [Persulfate] and
[B]0 = 22 mmol L-1, t = time (seconds) and k = second order reaction rate constant. The secondorder rate constant for persulfate and ciprofloxacin was determined by graphing the left-hand term
versus time (Figure 4.11). The slope was then set equal to ([B]0 − [A]0 ) k and the reaction rate,
k, calculated. In sulfate, persulfate level increased in a non-uniform fashion, likely due to the
complex set of reactions including sulfate radicals degrading ciprofloxacin, persulfate activation,
and interaction between ciprofloxacin and persulfate.
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Figure 4.9. Persulfate behavior during ciprofloxacin degradation
Single-cell RDE with anodic current density = 76 mA cm-2 and cathodic current density = 1.33
mA cm-2.
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Figure 4.10. Persulfate reduction to sulfate
[Persulfate]0 = 22 mmol L-1 and [Ciprofloxacin]0 =0.043 mmol L-1. Single-cell RDE with anodic
current density = 76 mA cm-2 and cathodic current density = 1.33 mA cm-2. BDD anode, combined
data for Gr and Pt cathodes.
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4.3.3 Radical roles in ciprofloxacin degradation
Quenching studies examined hydroxyl and sulfate radical roles in ciprofloxacin removal. Rate
constants for quenchers or ciprofloxacin with radicals are outlined in Table 4.7.

Table 4.7. Reaction Rate Constants for Quenching Experiments
Reactant

Reaction Rate Constant
with Hydroxyl Radicals
(M-1 s-1)

Reaction Rate Constant
with Sulfate Radicals
(M-1 s-1)

DMSO

6.7 x 109

207

3.0 x 109

208

TBA

6.0 x 108

158,42

4.0 x 105

158,42

Ciprofloxacin
(4.1 - 5.0) x 109 38, 209
*est. 106 - 109 76, 210
*estimate based on reaction rate of sulfate radical with many organic compounds

During DMSO quenching, virtually all radicals were predicted to react with DMSO over
ciprofloxacin (Equation 4.7a-b)211.
(4.7)

Competition kinetics for ciprofloxacin in quenchers211
𝑘𝑂𝐻_𝑐𝑖𝑝 [𝐶𝑖𝑝]

(a) 𝑓𝑂𝐻−𝐷𝑀𝑆𝑂 =

𝑘𝑂𝐻_𝑐𝑖𝑝 [𝐶𝑖𝑝]+𝑘𝑂𝐻_𝐷𝑀𝑆𝑂 [𝐷𝑀𝑆𝑂]

(b) 𝑓𝑆𝑂4−𝐷𝑆𝑀0 =
(c) 𝑓𝑂𝐻−𝑇𝐵𝐴 =
(d) 𝑓𝑆𝑂4−𝑇𝐵𝐴 =

𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]+𝑘𝑆𝑂4_𝐷𝑀𝑆𝑂[𝐷𝑀𝑆𝑂]
𝑘𝑂𝐻_𝑐𝑖𝑝 [𝐶𝑖𝑝]

𝑘𝑂𝐻_𝑐𝑖𝑝[𝐶𝑖𝑝]+𝑘𝑂𝐻_𝑇𝐵𝐴 [𝑇𝐵𝐴]
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]
𝑘𝑆𝑂4_𝑐𝑖𝑝 [𝐶𝑖𝑝]+𝑘𝑆𝑂4_𝑇𝐵𝐴 [𝑇𝐵𝐴]

= 1.3 x 10-5
= 6.5 x 10-7
= 1.5 x 10-4
= 4.9 x 10-3

For Equation 4.7: fOH−DMSO represents the fraction of hydroxyl radicals preferentially
reacting with ciprofloxacin instead of reacting with (being quenched by) DMSO,
fSO4−DSM0 represents the fraction of sulfate radicals preferentially reacting with ciprofloxacin
instead of reacting with (being quenched by) DMSO, fOH−TBA represents the fraction of hydroxyl
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radicals preferentially reacting with ciprofloxacin instead of reacting with (being quenched by)
TBA, fSO4−TBA

represents the fraction of hydroxyl radicals preferentially reacting with

ciprofloxacin instead of reacting with (being quenched by) TBA, [Cip] = concentration of
ciprofloxacin (0.043 mmol L-1), [TBA] = concentration of tert-butanol quencher (2200 mmol L-1),
[DMSO] = concentration of dimethyl sulfoxide quencher (2200 mmol L-1), kOH_cip = hydroxyl
radical-ciprofloxacin second order reaction rate constant listed in Table 4.7 (median value of 4.55
x 109 used for calculations), kSO4_cip = sulfate radical-ciprofloxacin second order reaction rate

constant listed in Table 4.7 (a value of 108 used for calculations based on those found for many
aromatic compounds)76, kOH_DMSO hydroxyl radical-DMSO second order reaction rate constant
listed in Table 4.7, kSO4_DMSO sulfate radical-DMSO second order reaction rate constant listed
in Table 4.7, kOH_TBA hydroxyl radical-TBA second order reaction rate constant listed in Table
4.7 and kSO4_TBA sulfate radical-TBA second order reaction rate constant listed in Table 4.7.
With DMSO addition, only 12% removal was observed in the nitrate solution (Figure 4.12).
Therefore, a portion of the removal in the nitrate solution, under non-quenched conditions, was
attributed to hydroxyl radicals, with electrode surface reactions, such as direct oxidation,
contributing the remaining portion. In sulfate or persulfate, a substantial reduction in removal was
also observed during DMSO quenching.

However, in these cases a significant portion of

degradation under non-quenched conditions was attributed to both hydroxyl and sulfate radicals.
While TBA is typically used to distinguish between sulfate and hydroxyl radicals, calculations
(Equations 4.7a-d) did not predict a significant difference in its ability to preferentially quench
sulfate radicals over hydroxyl radicals under current experimental conditions. Differences in
removal with the two quenchers may be attributable to actual differences in hydroxyl versus sulfate
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Figure 4.11. Second-order reaction modeling of ciprofloxacin and persulfate
Initial 0.043 mmol L-1 ciprofloxacin and 22 mmol L-1 persulfate. Single-cell RDE with anodic
current density = 76 mA cm-2 and cathodic current density = 1.33 mA cm-2.
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Figure 4.12. Quenching Experiments
Quenching Experiments. [Persulfate]0 or [Sulfate]0 = 22 mmol L-1. [Nitrate]0 = 66 mmol L-1.
[Ciprofloxacin]0 = 0.043 mmol L-1. Experiments completed in a single-cell RDE reactor at 76
mA cm-2 anodic current density with a BDD anode and Gr or Pt cathode (data is averaged for
cathodes since no significant difference was found between cathodes). 2200 mmol L-1 TBA used
to quench hydroxyl radicals. 2200 mmol L-1DMSO used to quench hydroxyl and sulfate radicals.
Time point of 120 minutes used to compare all samples.

radical reactivity, or may be due to differences in the ability of quenchers to suppress radicals, as
established by the competition kinetics fractional calculations (Equations 4.7c-d). Overall, the
decreasing ciprofloxacin degradation under quenched conditions suggests that one or both radicals
play a significant role in ciprofloxacin degradation using EAP. Of note is the ~35% removal
achieved in persulfate with primary radicals quenched. Radicals such as persulfate (S2O82-·), R·
(organic) and ROO· (organo-peroxide) may propagate from sulfate and hydroxyl radicals but have
limited potential to form because their parent radical is quenched96, 135, 151, 212. It is suggested that
non-radical based persulfate activation at the BDD anode is partially responsible for enhanced
ciprofloxacin removal in persulfate, which has recently been observed in other persulfate-based
systems42, 84, 213.
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4.3.4 Cyclic voltammetry
Cyclic voltammograms (C-V) were performed to clarify differences between electrolytes for
persulfate activation and ciprofloxacin abatement. Two distinct oxidation peaks for ciprofloxacin
were observed at the BDD anode (Figure 4.13) in all electrolytes, demonstrating that surface-based
oxidation of ciprofloxacin is likely partially responsible for the ciprofloxacin removal seen in
Figure 4.4. A third oxidation peak was marginally visible in sulfate and nitrate, but was more
prominent in persulfate, revealing that persulfate electrolyte may drive oxidation at a lower
voltage. Full C-Vs are shown in Figure 4.14. Multi-cycle C-Vs, displayed in Figure 4.15,
demonstrate ciprofloxacin oxidation is quasi-irreversible process, as there are no symmetric
reduction peaks and the oxidation peaks almost disappear after the first cycle. C-Vs were also
completed for graphite and platinum material (Figure 4.16), with focus on the reductive reactions
occurring at these cathodes (Figure 4.17). For nitrate and sulfate electrolytes, there were no
significant differences between cathode materials. Direct reduction of ciprofloxacin was not
observed in the potential range evaluated. An irreversible reduction peak at both cathodes is
observed when persulfate and ciprofloxacin are present in solution together. This indicates a
surface-based reaction between persulfate and ciprofloxacin, i.e., direct electrochemical persulfate
activation.
4.3.5 Using ciprofloxacin to evaluate persulfate activation
Further verification of electrochemical persulfate activation was established with ciprofloxacin
electrolysis in a split-cell RDE with BDD/Gr electrodes. Figure 4.18 shows a well-defined
difference in ciprofloxacin removal at the cathode in persulfate with pseudo-first order
(R2=0.9215) degradation, with respect to ciprofloxacin, in persulfate and 55% removal within 300
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Figure 4.13. Ciprofloxacin oxidation peaks during cyclic voltammetry using a BDD anode
C-Vs were run with multiple cycles to determine reversibility but only the first cycle is pictured
for clarity. “electrolyte only” are controls; other C-Vs with the addition of 0.043 mmol L-1
ciprofloxacin at 250, 500 and 750 mV s-1 scan rates. All C-Vs with 22 mmol L-1 sulfate or
persulfate, or 66 mmol L-1 nitrate.
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Figure 4.14. Complete cyclic voltammograms of ciprofloxacin using BDD anode
0.043 mmol L-1 ciprofloxacin in (a) 66 mmol L-1 nitrate b) 22 mmol L-1 sulfate or (c) 22 mmol L1
persulfate using a BDD anode at different scan rates. Numerical legend values are scan rates in
mV s-1. Electrolyte only baselines are scanned at 750 mV s-1.
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Figure 4.15. Multiple-cycle cyclic voltammograms of ciprofloxacin
0.043 mmol L-1 ciprofloxacin in (a) 66 mmol L-1 nitrate b) 22 mmol L-1 sulfate or (c) 22 mmol L1
persulfate using a BDD anode at a scan rate of 750 mV s-1. Prominent oxidation peaks are present
in the first cycle in all electrolytes. No oxidation peaks are present in nitrate after the first cycle.
In persulfate, a slight oxidation peak appears in subsequent cycles for sulfate and persulfate. These
voltammograms were similar at lower scan rates as well and illustrate the irreversible nature of the
ciprofloxacin oxidations.
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Figure 4.16. Cyclic voltammograms of ciprofloxacin using Pt or Gr anodes
All C-Vs with 22 mmol L-1 sulfate or persulfate, or 66 mmol L-1 nitrate. 0.043 mmol L-1
ciprofloxacin where indicated in legend.
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Figure 4.17. Reduction peak during cyclic voltammetry of cathode materials
Figures 4.17a and c: C-Vs of (a) electrolyte control and (c) electrolyte with ciprofloxacin, both
completed with graphite electrode. Figure 4.17 b and d: C-Vs of (b) electrolyte control and (d)
electrolyte with ciprofloxacin, both completed with platinum electrode. All C-Vs with 22 mmol
L-1 sulfate or persulfate, or 66 mmol L-1 nitrate. C-Vs c. and d. include the addition of 0.043 mmol
L-1 ciprofloxacin.
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Figure 4.18. Ciprofloxacin removal in a split-cell reactor
Ciprofloxacin removal and corresponding persulfate concentration in a split-cell RDE. Anodic
current density = 28.5 mA cm-2. Cathodic current density = 1.33 mA cm-2. [Ciprofloxacin]0 =
0.043 mol L-1. (a-b) [Persulfate]0 22 mmol L-1. (c-d) [Sulfate]0 = 22 mmol L-1.
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minutes (Figure 4.18a) versus no removal in sulfate electrolyte (Figure 4.18c). These results,
combined with C-V analysis, provide strong experimental evidence of persulfate activation at the
cathode, verifying what other studies have previously postulated59,
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.

While persulfate

transformation at the anode did not occur (Figure 4.18b) and sulfate was not available to form
sulfate radicals, some ciprofloxacin removal was still observed at the anode in persulfate, with
reaction rates of 1.1x10-4 s-1 and 5.1x10-5 s-1 in sulfate and persulfate, respectively. Quenching
results suggested that non-radical persulfate activation at the BDD anode may account for
ciprofloxacin removal in the anode cell.
Persulfate activation and regeneration were observed with organic analyte in solution
(Figures 4.18b and d) as without organic analyte (Figure 4.2b and c). Persulfate decomposition at
the cathode (Figure 4.18b) did not exhibit pseudo-first order decay with respect to persulfate as
seen in the single-cell solution even though ciprofloxacin was present. This pseudo-first order
mechanism may result from a synergistic effect between reactions at the anode and cathode.
4.3.6 Ciprofloxacin transformation
Ciprofloxacin transformation pathways were examined in the three electrolytes, as shown in Figure
4.19. Mass spectra corresponding to by-products shown in Figure 4.19 are presented in Appendix
Figures A13a-u. In persulfate, rapid defluorination occurred within 15 minutes (Figure 4.20),
corresponding to the rapid ciprofloxacin removal observed in Figure 4.4.

A multi-point

hydroxylation with fluoride substitution (Figure 4.19), through m/z 362, was identified as a
dominant route for ciprofloxacin breakdown in persulfate.

Similar mechanisms involving

hydroxylation and/or defluorination were observed in multiple studies44,96,176,184,194. Ciprofloxacin
defluorination (Figure 4.20) reached >90% in both persulfate and sulfate, which is important
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Figure 4.19. Ciprofloxacin Transformation Pathways
Primary persulfate pathways through m/z 362 and 264. Primary sulfate pathway through m/z 264.
Primary nitrate pathways through m/z 264 and 362. Secondary pathway in all three electrolytes
through m/z 328.
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Figure 4.20. Defluorination of ciprofloxacin
Defluorination of 0.043 mmol L-1 ciprofloxacin with a BDD anode and graphite or platinum
cathode. Single-cell RDE with anodic current density = 76 mA cm-2 and cathodic current density
= 1.33 mA cm-2. (a) [Persulfate]0 = 22 mmol L-1 (b) [Sulfate]0 = 22 mmol L-1 (c) [Nitrate]0 = 66
mmol L-1.
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because defluorination may lower toxic effects of fluorinated contaminants176. Defluorination in
nitrate only reached 36%. Fluoride removal in sulfate and nitrate was almost linear, indicating a
surface-dominated mechanism. Hydroxylation without defluorination, through m/z 264, was a
major degradation route in all electrolytes and the dominant pathway in nitrate and sulfate. A third
pathway, breakdown of the core quinolone structure through m/z 328, was comparable to results
observed in other studies44, 96.
Additional key mechanisms here and other ciprofloxacin studies include: 1) piperazinering cleavage44, 96, 176, 184, 194, 214, 2) cyclo-propyl group breakdown 44, 3) loss of amines44, 184, and
4) decarboxylation96, 184, 214. No significant differences were noted between cathode materials.
While no sulfate-adducts were observed, possible nitrate-adduct formation indicates potential
nitrate radical evolution at the BDD anode in nitrate. Overall, electrochemically generated sulfate
radicals resulted in additional degradation pathways corresponding to the enhanced ciprofloxacin
and TOC removal observed in sulfate and persulfate solutions.
4.4 Conclusion
Based on this study’s results, anodic sulfate radical formation, anodic non-radical persulfate
activation and cathodic persulfate activation are expected to contribute to accelerated removal rates
of organic analytes susceptible to activated persulfate reactions. This study screened EAP as a
viable candidate for point source treatment of wastewaters contaminated by fluoroquinilone
antibiotics like ciprofloxacin. Future work should include analysis of reactions in real-water
matrices (including presence of inorganic ions and high TOC levels) and application to other
analytes. Reactor design must also be considered, including flow-through single-cell reactors,
where mass transfer limitations to electrode surface might impact the system’s ability to effectively
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activate persulfate and subsequently degrade antibiotics. Further investigation is warranted in
determining the efficacy of EAP for real-world application.
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CHAPTER FIVE: CIPROFLOXACIN DEGRADATION IN SYNTHETIC HOSPITAL
EFFLUENT
5.1 Introduction
For scale-up of EAP from laboratory to practical application, more must be understood about
variables affecting EAP degradation results. These include effects of persulfate concentration,
reactor configuration, sizes of electrodes and how the system performs when applied to complex
wastewaters.
A significant concern with the use of electrochemical treatment of organic effluents is the
formation of organic and inorganic disinfection by-products (DBPs), which can occur in reactive
systems that contain both halogens and organic matter46, 215. During electrochemical treatment of
water using a BDD anode, hydroxyl radicals formed at the BDD surface reacted with halogens to
create halogenated radical species135. These halogenated radical species have the potential to react
with organics in solution to create trihalomethanes and halo-acetic acids216. Hydroxyl radicals
also can oxidize chloride ions to progressively form hypochlorite, chlorite, chlorate and
perchlorate ions135, 215, 217. One study generated significant levels (1-2 mg L-1) of chlorate and
perchlorate during the electrochemical post-treatment of chlorinated drinking water217. Another
study treating clofibric acid in synthetic secondary wastewater effluent generated over 100 mg L1

perchlorate using a BDD anode, well above the US EPA’s drinking water health advisory of 15

µg L-1 218. Finally, the inorganic DBP nitrite can form by oxidation of nitrate at the anode surface
in slightly basic solutions219.
In an activated persulfate system, the same hydroxyl-based radicals that are active in
electrochemical systems can create organic and inorganic DBPs216, 220. The accelerated organic
101

degradation found by combing electrochemical reactions with activated persulfate reactions in an
EAP system may compound the effect. It is imperative that DBP formation in EAP systems is
understood to prove the feasibility of using persulfate addition as a means for treating complex
wastewater matrices.
Ciprofloxacin is a fluoroquinolone antibiotic that is known to degrade electrochemically in
sulfate and persulfate solutions, as shown in Chapter 4194. Because of its high environmental risk
factor29, ciprofloxacin was chosen as a model compound for this study and will be used to explore
parameters influencing EAP for environmental contaminant removal.
The first objective of this study is to evaluate reactor configurations for use with EAP.
Ciprofloxacin removal during the EAP process was studied in a rotating-disk electrode (RDE)
reactor, a batch reactor, and a flow-through reactor (FTR). The second objective of the study is to
establish effects of variable persulfate concentration and cathode size on ciprofloxacin removal
using EAP. Third, ciprofloxacin degradation will be analyzed using EAP in a “real-world” matrix.
To accomplish this objective, EAP was applied to ciprofloxacin removal from synthetic hospital
effluent. Kinetics of ciprofloxacin decay were compared to that in pure electrolyte. Finally, this
study aims to evaluate inorganic DBP formation during treatment of ciprofloxacin in synthetic
hospital effluent. This step was completed for FTR and RDE reactor configurations.
5.2 Materials and Methods
5.2.1 Chemicals
Ciprofloxacin (98%), sodium persulfate (98%), potassium sulfate, sodium nitrate, potassium
iodide (99+%), urea, uric acid, DL-tyrosine (98%), creatinine (99+%), sodium bicarbonate (Acros
Organic), Optima formic acid, Optima Methanol (MeOH), magnesium perchlorate, RICCA
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sodium chlorite (80%), sodium chloride, ammonia chloride, potassium phosphate monobasic, and
fluoride standard were purchased from Fisher Scientific (Pittsburg, PA) and 1N sulfuric acid was
from J.T. Baker. Deionized water (DI) (18.2 MΩ-cm) was produced by a Millipore Milli-Q
system.
5.2.2 Experimental Setup
Initial ciprofloxacin concentrations were 0.043 mmol L-1 for all experiments (after addition of
electrolyte and effluent as noted below), with ciprofloxacin preparation as described in Chapter 4.
All experiments were spiked with concentrated electrolyte to the desired concentration just before
applying current, as described in Chapter 4.
For hospital effluent experiments, concentrated hospital effluent was prepared in advance,
with components shown in Table 5.1. The synthetic effluent was mixed with ciprofloxacin before
electrolyte was added. Synthetic hospital effluent composition for all experiments is shown in
Table 5.1 and is based on values determined experimentally in other publications28, 221. Total
organic carbon, at a level of 221 mg/L, consisted of ciprofloxacin plus a mixture of urea, uric acid,
creatinine and tyrosine as outlined in Table 5.1. Tyrosine has been shown to react with chlorine
to form various organic chlorinated by-products222. Urea and creatinine are major constituents of
human urine, and uric acid is a minor constituent; all three are expected to be present in hospital
wastewater223.
FTR experiments were conducted using apparatus depicted in Figure 5.1. A boron-doped
diamond (BDD) anode and graphite cathode were used (both surface areas 18 cm2). Recirculation
was maintained at 16mL min-1. The effective treatment time was calculated by equation 5.1132:
(5.1)

𝑡𝑒𝑓𝑓 = 𝑡𝑎𝑐𝑡𝑢𝑎𝑙 ∗

𝑟𝑒𝑎𝑐𝑡𝑜𝑟 𝑣𝑜𝑙𝑢𝑚𝑒
𝑡𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
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Table 5.1. Synthetic Hospital Effluent Composition for EAP Degradation of
Ciprofloxacin
Compound

Ion/Molecule

Formula

Ion Concentration
(mg L -1)

Potassium Sulfate

Sulfate

SO42-

34.6

Potassium Nitrate

Nitrate

NO3-

18.0

Ammonium Chloride

Ammonium

NH4+

30.7

Potassium Phosphate Monobasic

Phosphate

HPO4-

81.5

(Ammonium-, Sodium- ) Chloride

Chloride

Cl-

150.2

Sodium (-Chloride, -Bicarbonate)

Sodium

Na+

85.5

Potassium (-Phosphate Monobasic, Sulfate, -Nitrate)

Potassium

K+

74.4

Sodium Bicarbonate

Bicarbonate

HCO3-

73.0

TOC

221

Total Organic Carbon
Urea

Urea

CH4N2O

800 (160 mg L-1 TOC)

Uric Acid

Uric Acid

C5H4N4O3

2.0 (0.71 mg L-1 TOC)

Tyrosine

Tyrosine

C9H11NO34

2.0 (1.2 mg L-1 TOC)

Creatinine

Creatinine

C4H7N3O

118 (50 mg L-1 TOC)

Ciprofloxacin

Ciprofloxacin

C17H18FN3O3

14 (8.6 mg L-1 TOC)
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Figure 5.1. Schematic of the flow-through cell
Valves are used to allow for sampling.

The reactor volume was 36.5 mL and initial solution volume was 1000 mL. A BK
Precision 1761 DC power supply purchased from Cole Parmer was used to maintain a current of
125 mA (current density = 6.9 mA cm-2) for all FTR experiments.
Batch reactor experiments were conducted using the apparatus depicted in Figure 5.2. A
BDD anode and graphite cathode were used (both surface areas 18 cm2). Stirring was maintained
with a magnetic stir bar. Initial solution volume was 500 mL. The same BK Precision power
supply was used to maintain a current of 125 mA (current density 6.9 mA cm-2) for all batch
experiments. An SP-150 potentiostat (Bio-Logic Science Instruments, Knoxville, TN) with a
mercury-mercury sulfate reference electrode was used to perform rotating disk electrode (RDE)
experiments with schematic provided in Chapter 4 (Figure 4.1a). A multi-speed rotator (Pine
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Figure 5.2. Schematic of batch reactor

Research Instrumentation, PRI, Durham, NC) set to 2000 rpm was used for the RDE experiments
and bulk mixing was maintained using a magnetic stir-bar. The anode was a change-disk RDE tip
(PRI) with BDD electrode insert of 0.196 cm-2 surface area (Fraunhofer Center for Coatings and
Diamond Technologies, East Lansing, MI). The cathodes were Electron Microscopy Science
graphite (Gr) rods (Fisher Scientific, Pittsburg, PA) with 4.8 cm2 exposed to solution except as
noted. Experiments were conducted with 200-mL solution volumes with a constant current of 15
mA (76 mA cm-2 current density).
Experiments were completed at 20˚C with an initial pH of 4.0 for experiments in the pure
electrolyte and 7.05 for experiments in the synthetic hospital effluent. pH was not buffered in
these experiments to prevent impacts due to buffering ions141. Average final pHs were consistently
2.15-2.5 in persulfate electrolyte, with or without effluent. In sulfate electrolyte, pH did not change
during the reactions in the batch reactor. In the FTR and RDE reactors, pH increased during
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reactions in pure sulfate electrolyte, ending at 8.0 in the FTR and 6.5 in the RDE reactor. With
sulfate in the effluent, average final pHs were 2.5-3.0 for both reactor configurations.
5.2.3 Analytical Methods
Persulfate and ciprofloxacin-matrix concentrations were analyzed using a ThermoScientific
Evolution 600 UV/Vis spectrometer (ThermoFisher, Pittsburg, PA) at 272 and 352 nm,
respectively, with methodology described in Chapter 3180, 181, 191.
HPLC-UV was used for direct ciprofloxacin analysis. Samples were prepared by extraction
with Waters Sep-Pak tC2 cartridges as follows: conditioning with 1-mL methanol/1-mL DI water;
loading 1-mL sample; extracting with 2x1-mL quantities of methanol/0.1% formic acid191.
Extraction efficiency was 80%. Detailed methodology and statistical parameters were described
in Chapter 4 and applied in this study.
A Shimadzu HPLC with Hypersil Gold column (100 mm long, 4.6 I.D., 5-micron particles)
and detection by a SPD-M20A diode array detector at 278 nm was used to quantify ciprofloxacin,
as described in Chapter 4.
A Shimadzu TOC-L analyzer with an ASI-L autosampler was used to analyze TOC.
Statistical parameters for the method were described in Chapter 3191.
A ThermoFisher fluoride ion selective probe was used to analyze fluoride (F-) concentrations.
TISAB II was added in equal amounts to samples and standards, to act as an ionic strength buffer
and dissociate potential hydrofluoric acid. Statistical parameters for the calibration curve are
found in Table 5.2. The method detection limit was 0.012 mmol L-1.
Ion chromatography was used to analyze the inorganic disinfection by-products chlorite,
chlorate, perchlorate and nitrite. A Dionex 2100/1100 dual column system with background
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suppression was used. Statistical parameters for the calibration curves for these ions are found in
Tables 5.3-5.6. The method detection limit for chlorite was 4.7 x 10-3, chlorate was 1.7 x 10-4mmol
L-1, perchlorate was 1.7 x 10-2 mmol L-1 and nitrite was 3.8 x 10-4 mmol L-1.

Table 5.2. Statistical Parameters for Fluoride Calibration Curve

Value
Standard error
R2

Slope
(mV per LN (mmol L-1 F-))
-22.0
0.50
0.9979

Intercept
(mV)
28.0
1.86

Table 5.3. Statistical Parameters for Chlorite Calibration Curve

Value
Standard error
R2

Slope
(peak area per mmol L-1)
8.32
0.22
0.9971

Intercept
(peak area)
0.017
0.034

Table 5.4. Statistical Parameters for Chlorate Calibration Curve

Value
Standard error
R2

Slope
(peak area per mmol L-1)
9.44
0.01
0.9996

Intercept
(peak area)
-0.065
0.029

Table 5.5. Statistical Parameters for Perchlorate Calibration Curve

Value
Standard error
R2

Slope
(peak area per mol L-1)
7.23
0.13
0.9989

Intercept
(peak area)
-0.040
0.016
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Table 5.6. Statistical Parameters for Nitrite Calibration Curve

Value
Standard error
R2

Slope
(peak area per mol L-1)
8.40
0.11
0.9992

Intercept
(peak area)
-0.031
0.011

5.3 Results
5.3.1 FTR experiments
In Chapter 4, persulfate addition was shown to enhance removal of ciprofloxacin in a RDE reactor.
To better assess reactor configuration for practical application, experiments to electrochemically
degrade ciprofloxacin in a FTR and batch reactor were performed in sulfate and persulfate
electrolytes. At the same time, different levels of persulfate electrolyte were evaluated to optimize
the amount of persulfate recommended for these systems.
FTR results are shown in Figure 5.3. Based on Chapter 4 results, it was expected that
persulfate would offer an advantage over sulfate for electrochemical ciprofloxacin removal, due
to persulfate activation at the cathode. In 11 mmol L-1 persulfate, 95% of ciprofloxacin and 66%
of TOC were removed in teff = 60 minutes. Degradation followed pseudo-first-order kinetics, with
ciprofloxacin-matrix keff = 9.53 +/- 1.03 x 10-4 s-1 and TOC keff = 3.16 +/- 0.45 x 10-4 s-1. The fit
for pseudo-first order was R2 = 0.9549 for ciprofloxacin-matrix and R2 = 0.9276 for TOC. Similar
results were found in 11 mmol L-1 sulfate electrolyte with 92% removal of ciprofloxacin-matrix
and 61% removal of TOC in teff = 60 minutes. Removal in sulfate also followed first-order kinetics
with ciprofloxacin-matrix keff = 7.68 +/- 0.57 10-4 s-1 (R2=0.9768) and TOC keff = 2.64 +/- 0.65
x 10-4 s-1 (R2=0.8259). Removal of the ciprofloxacin-matrix was a statistically significant 19%
faster in persulfate than sulfate (p=0.0016).

TOC removal was not statistically different

(p=0.1631).
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Figure 5.3. Degradation of ciprofloxacin-matrix and TOC in a flow-through reactor
Sulfate0 = Persulfate0 = 11 mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA
cm-2.

Defluorination, shown in Figure 5.4, reached 100% and was similar in both electrolytes.
After an initial spike of defluorination with the addition of electrolyte, the ciprofloxacin
defluorinated linearly with the square root of time (Figure 5.4b). Because fluoride removal may
lower the toxicity of fluorinated pharmaceuticals, defluorination is a significant outcome in the
treatment of such compounds 189.
Persulfate reduction, determined in Chapter 4 to indicate persulfate activation in an RDE
system, was confirmed to occur in the FTR (Figure 5.5a) via a pseudo-first order (Figure5.5b)
mechanism with respect to persulfate. Persulfate generation from sulfate, previously established
in an RDE system, was also confirmed in the FTR (Figure 5.5a). Because of the small difference
in ciprofloxacin removal and lack of difference in TOC removal between no persulfate (sulfate
only) and a high level of persulfate (11 mmol L-1), intermediate levels were not tested.
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Figure 5.4. Defluorination of ciprofloxacin in a FTR
(a) Defluorination of ciprofloxacin in persulfate and sulfate electrolytes in an electrochemical FTR.
(b) Modeling for Figure 5.4a. (a-b) Sulfate0 = Persulfate0 = 11 mmol L-1. Ciprofloxacin0 = 0.043
mmol L-1. Current density 6.9 mA cm-2.
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5.3.2 Batch Reactor Experiments
Batch reactor results for electrochemical ciprofloxacin degradation are shown in Figure 5.6.
Several levels of persulfate concentration were employed to better understand the limited
difference in ciprofloxacin removal between persulfate levels on the FTR. Ciprofloxacin-matrix
and TOC removal both followed pseudo-first order kinetics with respect to themselves, as
illustrated in Figures 5.6a and 5.6b respectively. Reaction rate constants and statistics for the
curves in Figure 5.6 are shown in Table 5.7. Ciprofloxacin-matrix removal ranged from 92.5%
without persulfate to 94% at 3.1 mmol L-1 persulfate to 96.5% in 11 mmol L-1 persulfate, all in
300 minutes. The removal rate with the high level of persulfate (k = 1.83 +/- 0.13 10-4 s-1 ) was a
statistically significant 25% greater than with sulfate alone (k = 1.37 +/- 0.12 10-4 s-1 ), at
p<0.0001. With less persulfate (3.1 mmol L-1) the 11% increase in rate was also significant
(p=0.0325).

TOC removal in the same timeframe averaged 78% and was not statistically

significant without or with persulfate. As shown in Figure 5.6c, the ciprofloxacin-matrix reaction
rate constant increased linearly (R2=0.9360) with increasing persulfate concentration (Figure
5.6c). The pseudo-first order reaction rate constant (r) vs. persulfate concentration was modeled
as r=(3.94x10-6) x c + (1.36x10-4), where c is mmol L-1 persulfate.
Defluorination (Figure 5.7) was similar without persulfate and with high persulfate (11
mmol L-1) and reached ~85%, so intermediate levels were not evaluated. Defluorination increases
linearly with the square root of time, as shown in Figure 5.7b, so the provided equations on Figure
5.7b can be used to predict defluorination in this system.

112

Figure 5.5. Persulfate behavior during ciprofloxacin removal in a FTR
(a) Persulfate concentration over time during ciprofloxacin removal in an electrochemical FTR.
(b) Modeling for Figure 5.5a. (a-b) Sulfate0 = Persulfate0 = 11 mmol L-1. Ciprofloxacin0 = 0.043
mmol L-1. Current density 6.9 mA cm-2.
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Figure 5.6. Degradation of ciprofloxacin-matrix and TOC in in a batch reactor
Sulfate0 or Persulfate0 shown on legend. Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA
cm-2.

114

Table 5.7. Reaction rate constants and statistics for batch reactor with varying persulfate
levels
Persulfate
(mmol L-1)

Pseudo-first order reaction
rate constant
X 10-4 (s-1)
Ciprofloxacin-matrix
11*
1.83
5.5*
1.58
3.1
1.54
0
1.37
TOC
11
0.70
5.5
0.72
3.1
0.70
0
0.72

+/-

R2
first-order
fit

% difference
from sulfate

Statistical significance of
difference from sulfate

0.13
0.16
0.12
0.12

.9790
.9722
.9843
.9794

25%
13%
11%
n/a

p < 0.0001
p=0.0325
p=0.037
n/a

0.08
0.06
0.40
0.07

.9519
.9771
.9855
.9755

3%
0%
3%
n/a

p=0.8305 (not sig.)
p=0.9041 (not sig.)
p=0.7471 (not sig.)
n/a

*Difference between 11 and 3.1 was also a statistically significant 16% with p=0.0032; difference between 11 and
5.5 was also a statistically significant 14% with p=0.0217.

Persulfate reduction and persulfate generation from sulfate is shown in Figure 5.8.
Persulfate reduction occurred via a first-order mechanism as shown in Figure 5.8b.
It was suspected that the 1:1 anode:cathode ratio utilized in the batch and flow-through reactor
make these anode dominant processes, so that persulfate activation at the cathode is not a
significant contributor to degradation, especially for TOC removal. Chapter 4, in which cathodic
persulfate activation influenced degradation, had an anode:cathode size ratio of 1:24 with an RDE
setup, much different than the 1:1 ratio for experiments described thus far in the current study. It
was also hypothesized that mass transfer limitations, minimized in the previous study through use
of an RDE, inhibited the ability of radicals formed at the anode or cathode to be effective in
solution. Mass transfer limitations would increase going from an RDE configuration with anode
rotation at 2000 rpm, to a batch reactor with stirring maintained in the vessel, to a flow-through
reactor with flow parallel to the reactor plate. This expectation follows the observed decrease in
persulfate effectiveness from RDE (Chapter 4) to batch to FTR.
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Figure 5.7. Defluorination of ciprofloxacin in a batch reactor
(a) Defluorination of ciprofloxacin in persulfate and sulfate electrolytes in an electrochemical
batch reactor. (b) Modeling for Figure 5.7a. (a-b) Sulfate0 or Persulfate0 = 11 mmol L-1.
Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA cm-2.
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Figure 5.8. Persulfate behavior during ciprofloxacin removal in a batch reactor
(a) Persulfate concentration over time for ciprofloxacin removal in a batch reactor. (b) Modeling
for Figure 5.8a. (a-b) Persulfate0 indicated on legend. Sulfate0 =11 mmol L-1 (Figure 5.8a inset).
Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA cm-2.
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5.3.3 RDE reactor experiments
To understand fundamental effects of cathode size, experiments were completed with an RDE
while varying anode:cathode ratios (Figure 5.9). Pseudo-first order reaction rate constants and
related statistics are provided in Table 5.8. Ciprofloxacin-matrix removal rate was significantly
inhibited with an anode:cathode ratio of 1:1. There was a statistically significant 32% increase in
reaction rate going from a ratio of 1:1 to 1:10, with further increases in cathode size having
negligible effect on the ciprofloxacin-matrix. For TOC, reaction rates had a statistically significant
26% increase when cathode size increased to a ratio of 1:20 and continued to increase slightly up
at a 1:40 ratio. In comparison, changing the anode:cathode from 1:1 to 1:30 for removal in nitrate
electrolyte (an anode dominant process) did not change removal rates.

It is clear that

anode:cathode ratio must be considered when designing an EAP process, and that a smaller, more
expensive and brittle BDD can be used relative to a larger, less expensive graphite material. To
optimize removal time for both ciprofloxacin-matrix and TOC, a minimum of 1:20 anode: cathode
size is recommended for use with a BDD/Gr pair.
Persulfate activation, measured by net persulfate reduction, was also evaluated. Increasing
persulfate activation was observed for increasing cathode size (Figure 5.10). Persulfate increased
with the square root of increasing cathode:anode ratio, as shown on Figure 5.10d.
Ciprofloxacin removal versus varying persulfate concentration was next evaluated on the
RDE to understand the fundamentals effects of increasing persulfate levels when mass transfer
limitations are minimized. Ciprofloxacin-matrix and TOC removal are shown in Figure 5.11.
Both degraded via pseudo-first order mechanisms with respect to themselves, with reaction rates
and related statistics shown in Table 5.9. The maximum degradation rate occurred in 11 mmol L118

Figure 5.9. Ciprofloxacin-matrix and TOC removal with varying anode:cathode ratios
(a-b) Degradation of ciprofloxacin-matrix and TOC in an RDE over time in persulfate electrolyte
with various anode:cathode ratios as noted in legend. (c-d) Reaction rate constants versus relative
cathode size for curves shown in (a-b). Persulfate0 = 22 mmol L-1. Ciprofloxacin0 = 0.043 mmol
L-1. Current density mA cm-2. Also shown, reaction rate constants for degradation of
ciprofloxacin-matrix and TOC in an RDE over time in nitrate electrolyte under same conditions
and nitrate0 = 22 mmol L-1.
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Table 5.8. Reaction rate constants and statistics for RDE with varying anode:cathode size
Pseudo-first order
reaction
rate
constant
X 10-5 (s-1)
Ciprofloxacin-matrix/persulfate*
1:40
3.93
1:30
3.57
1:20
3.67
1:10
3.65
1:1
2.51
TOC from Ciprofloxacin/persulfate*
1:40
0.88
1:30
0.82
1:20
0.72
1:10
0.63

+/-

R2
for firstorder fit

% difference
from 1:1

Statistical significance
of difference from 1:1

0.29
0.38
0.25
0.33
0.20

.9850
.9635
.9843
.9774
.9782

36%
32%
32%
32%
n/a

p<0.0001
p<0.0001
p<0.0001
p<0.0001
n/a

0.14
0.21
0.11
0.21

.9211
.8424
.9303
.7291

40%
35%
26%
16%

p<0.0001
p=0.0109
p=0.0136
p=0.3861 (not sig.)

1:1

0.11

.8623

n/a

n/a

0.10
0.23

0.8094
0.5996

-22%
n/a

p=0.9753 (not sig.)
n/a

0.036
0.12

0.1260**
0.0795**

67%
n/a

p=0.3297 (not sig.)
n/a

Ratio of size
(anode:cathode)

0.53

Ciprofloxacin-matrix/nitrate*
1:30
0.40
1:1
0.49
TOC from Ciprofloxacin/nitrate*
1:30
0.036
1:1
0.012

*Experiments conducted in 22 mmol L-1 electrolyte
**Poor statistics due to almost no removal in 24-hours for either case
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Figure 5.10. Persulfate behavior with different cathode sizes during ciprofloxacin removal
in a RDE reactor
(a) Persulfate versus cathode size cathode sizes (b) Persulfate pseudo-first order reaction rate
constant versus cathode size (relative to anode size) (c) Modeling for Figure 5.10a. (a-b)
Persulfate0 = 11 mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 15 mA cm-2.
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persulfate electrolyte, with 80% ciprofloxacin-matrix removal achieved in 10 hours, and 65%
TOC removal achieved in 24 hours. The ciprofloxacin removal rate constant of k = 4.5 +/- 0.28
10-5 s-1 in 11 mmol L-1 persulfate was 44% greater than the rate without persulfate, at p<0.0001.
The TOC removal rate constant of k = 1.20 +/- 0.13 in 11 mmol L-1 persulfate showed even greater
gains, with a statistically significant 53% increase versus no persulfate. The removal rate declined
when doubling the persulfate from 11 to 22 mmol L-1. A maximum persulfate level beyond which
degradation plateaus or decreases has been shown in other studies and is likely due to sulfate
radicals scavenging themselves 48. At a lower 3.1 mmol L-1 persulfate, 30% faster removal rates
for both ciprofloxacin-matrix (k = 3.67 +/- 0.13) and TOC (k = 0.82 +/- 0.13) were achieved,
resulting in statistically significant great improvements over no persulfate for the ciprofloxacinmatrix degradation rate (p<0.0001) and the TOC degradation rate (at p=0.0410). Using 3.1 mmol
L-1 persulfate offers the benefits of enhanced analyte removal while limiting the addition of sulfate
to the system to 6.2 mmol L-1 (600 mg L-1) from persulfate reduction (as demonstrated in Figure
4.10) and may be considered an optimum level for this system. The fundamental relationship of
ciprofloxacin-matrix removal versus varying persulfate concentration was elucidated in Figure
5.11c. The reaction rate constants of ciprofloxacin-matrix and TOC both increased with the square
root of persulfate concentration up to 11 mmol L-1, with R2 values of 0.8933 and 0.9325
respectively.
The smaller, or in some cases lack of, difference between ciprofloxacin-matrix and TOC
removal rates at higher and lower persulfate levels in the batch and flow-through reactors are
attributed to the use of a 1:1 anode:cathode ratio as well as mass transfer limitations. For EAP,

122

Figure 5.11. Ciprofloxacin-matrix and TOC removal with varying persulfate levels
(a-b) Degradation of ciprofloxacin-matrix and TOC in an RDE over time in varying levels of
persulfate electrolyte. (c) Reaction rate constants versus square root of persulfate concentration
(*1.1 mmol L-1 persulfate level not shown in a-b for clarity but included in trend on c). Persulfate0
= 22 mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 15 mA cm-2.
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Table 5.9. Reaction rate constants and statistics for RDE reactor with varying persulfate
levels
Persulfate
(mmol L-1)

Pseudo-first
order reaction
rate constant
X 10-5 (s-1)
Ciprofloxacin-matrix
22*
3.58
11
4.50
5.5
3.90
3.1
3.67
1.1*
2.82
0
2.53
TOC
22*
0.96
11
1.20
5.5
0.93
3.1
0.82
1.1*
0.83
0
0.57

R2
for firstorder fit

%
difference
from sulfate

Statistical
significance
of
difference from
sulfate

0.17
0.28
0.30
0.35
0.18
0.22

.9626
.9801
.9808
.9724
.9868
.9635

29%
44%
35%
31%
10%
n/a

p < 0.0001
p < 0.0001
p < 0.0001
p < 0.0001
p=0.0588
n/a

p=0.0184
p=0.2958
p=0.8838
p=0.0588
n/a

0.19
0.13
0.18
0.13
0.13
0.25

.9648
.9686
.8725
.9377
.9361
.7764

41%
53%
39%
30%
30%
n/a

p=0.0138
p < 0.0001
p=0.0206
p=0.0410
p=0.0344
n/a

p=0.0001
p=0.2844
p=0.0001
p=0.0344
n/a

+/-

Statistical
significance
from previous increment
(i.e. 3.1 vs 1.1)

*Not shown on Figure 5.11

reactor design plays a critical role in the effectiveness of the system, as mass transfer must be
maximized and anode:cathode ratio must be optimized. As in the flow-through and batch reactors,
defluorination was not statistically different between 0 and 11 mmol L-1 (Figure 5.12). There was
also no effect by cathode size. Defluorination increased linearly with time, demonstrative of a
surface-based reaction.

It was concluded that defluorination is dominated by an anodic

electrochemical mechanism versus an EAP or cathodic mechanism.
Persulfate activation, demonstrated by persulfate reduction, occurred through a first-order
mechanism, as shown in Figure 5.13a-b. Persulfate generation from sulfate is demonstrated in the
inset. The persulfate curves in Figures 5.5b, 5.8b and 5.13b for FTR, batch and RDE respectively,
all show a linear relationship between LN (C/C0) with time, so it was concluded that persulfate
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activates by a pseudo-first order mechanism, with respect to persulfate, across reactor
configurations.

Figure 5.12. Defluorination of ciprofloxacin in a RDE reactor
(a) Defluorination of ciprofloxacin in persulfate and sulfate electrolytes in a RDE reactor. Sulfate0
or Persulfate0 = 11 mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 15 mA cm-2.

5.3.4 Second-order mechanisms
Although environmental contaminant degradation research relies almost solely on establishing
pseudo-first order rate constants with respect to the analyte being degraded, evaluating secondorder relationships may be useful for truly understanding fundamental mechanisms of decay. The
second-order relationships between persulfate and pure ciprofloxacin (extracted by SPE and
evaluated on HPLC/UV) was evaluated for the RDE configurations using equation 4.6. Results
are shown in Figure 5.14 and indicate a second-order mechanism between ciprofloxacin decay and
persulfate removal. Second-order rate constants calculated from the 11 and 3.1 mmol L-1
persulfate curves were 1.67 and 4.09 x10-2 L mol-1 s-1, respectively. These values are the same
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Figure 5.13. Persulfate behavior during ciprofloxacin removal in a RDE reactor
(a) Persulfate concentration with time. (b) Modeling for Figure 5.13a. (a-b) Persulfate0 indicated
on legend. Sulfate0 =11 mmol L-1 (Figure S9a inset). Ciprofloxacin0 = 0.043 mmol L-1. Current
density 15 mA cm-2.
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magnitude as the rate constant (2.10 x10-2 L mol-1 s-1) calculated for the 22 mmol L-1 persulfate
curve in Chapter 4. Combining the three curves gives a ciprofloxacin-persulfate second-order rate
constant of 2.62 +/- 1.46 x 10-2 L mol-1 s-1 in the RDE reactor.

Figure 5.14. Second-order modeling for the reaction of Ciprofloxacin and Persulfate
Persulfate0 = 3.1 and 11 mmol L-1 indicated on legend. Ciprofloxacin0 = 0.043 mmol L-1. Current
density 15 mA cm-2.

5.3.5 Ciprofloxacin degradation in synthetic hospital effluent
An important consideration when evaluating EAP for practical application is the system’s
performance for analyte removal in a “real-world” matrix. EAP was applied to ciprofloxacin
removal from synthetic hospital effluent using the FTR and RDE reactor configurations. The FTR
was utilized to demonstrate a reactor configuration that might be used in the field, while the RDE
was employed to elucidate fundamentals of EAP in a complex matrix. Results for ciprofloxacin
degradation in synthetic effluent in the FTR were compared to results obtained in pure electrolyte,
as shown in Figure 5.15. A pseudo-first order mechanism (with respect to listed analytes) for
decay of ciprofloxacin-matrix and TOC was found in the effluent as in pure electrolyte, with rate
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constants and related statistics shown in Table 5.10. Removal rates for ciprofloxacin-matric
decreased by 41% in the persulfate-effluent system and by 32% in the sulfate-effluent system. The
difference in removal rates previously seen between sulfate and persulfate was not found in the
effluent, so that persulfate did not offer an advantage for ciprofloxacin-matrix removal in the
synthetic effluent. While TOC removal rates in both electrolyte/effluent systems declined by just
over 50% versus pure electrolyte, of note is the 25x increase in TOC added by the effluent matrix.
The decrease in performance was much less than the TOC added and it was concluded that the
electrochemical FTR is capable of removing relatively high levels of TOC. This experiment was
unable to discern differences in TOC removal from ciprofloxacin versus the other organics in
solution. Persulfate provided a statistically significant (p=0.0010) 24% faster rate than sulfate for
TOC removal from effluent. EAP in an FTR may offer an advantage over sulfate for TOC removal
in complex matrices such as hospital effluent.
Defluorination in the effluent solution using the FTR followed the same pattern as in pure
electrolyte, with defluorination increasing with the square root of effective time, as seen in Figure
5.16. Less defluorination was achieved in effluent, in keeping with the lower rate of ciprofloxacinmatrix removal achieved. Defluorination in the sulfate-effluent system was higher than that in the
persulfate-effluent system, with 80% removal versus 62% in 60 minutes of effective time,
respectively. It may be the interactions of persulfate and effluent at the anode interfered with the
anode-dominated defluorination mechanism previously described.
Persulfate reduction in the effluent (Figure 5.17) followed the same trend as reduction in
pure persulfate (Figure 5.5). On the other hand, persulfate generation from sulfate was much less
in the effluent, with only 0.10 mmol L-1 detected over the 60-minute effective treatment time in
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Figure 5.15. Degradation of ciprofloxacin-matrix and TOC in synthetic hospital effluent in
a FTR.
Sulfate0 = Persulfate0 = 11 mmol L-1. TOC0=221 mg L-1 in effluent and 8.6 mg L-1 in pure
electrolyte. Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA cm-2.
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Figure 5.16. Defluorination of ciprofloxacin in synthetic hospital effluent in a FTR
(a) Defluorination with time. (b) Modeling for Figure 5.16a. (a-b) Sulfate0 or Persulfate0 = 11
mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA cm-2.
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Table 5.10. Reaction rate constants and statistics for FTR experiments in hospital effluent
+/-

R2
for
firstorder fit

% difference in
effluent
versus
electrolyte

Statistical significance of
difference in electrolyte
versus effluent

0.42
1.03

.9791
.9549

-41%

p < 0.0001

1.54
3.16

0.10
0.45

.9847
.9276

-51%

p < 0.0001

Ciprofloxacin-matrix/sulfate
Synthetic Effluent
5.25
Pure electrolyte
7.68

0.47
0.57

.9681
.9768

-32%

p < 0.0001

*TOC/sulfate
Synthetic Effluent
Pure electrolyte

0.19
0.65

.9058
.8259

-56%

p < 0.0001

Persulfate
(mmol L-1)

Pseudo-first
order
reaction
rate constant
X 10-4 (s-1)
Ciprofloxacin-matrix/persulfate
Synthetic Effluent
5.65
Pure electrolyte
9.53
*TOC/persulfate
Synthetic Effluent
Pure electrolyte

1.17
2.64

*Note that starting TOC was significantly higher in the effluent, going from 8.6 mg L -1 in pure electrolyte to 221 mg
L-1 in effluent
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Figure 5.17. Persulfate behavior during ciprofloxacin removal in synthetic hospital effluent
in a FTR
Sulfate0 or Persulfate0 =11 mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 6.9 mA
cm-2.
effluent versus the accumulation of 1.0 mmol L-1 in the same time in pure sulfate electrolyte.
Similar to defluorination, the interaction of the effluent at the anode may interfere with formation
of persulfate from sulfate at the anode.
During experiments using the RDE, extracted ciprofloxacin (separated by SPE and
measured by HPLC) was measured in addition to ciprofloxacin-matrix to study differences that
may occur in molecular ciprofloxacin removal versus the ciprofloxacin-matrix.

Extracted

ciprofloxacin was analyzed in pure electrolyte and effluent. The pure ciprofloxacin degraded via
pseudo-first order mechanisms, with respect to ciprofloxacin concentration, in all solutions, with
reaction rate constants and statistics provided in Table 5.11. In pure electrolyte, differences in
removal between persulfate levels was similar for molecular ciprofloxacin as for the ciprofloxacinmatrix, although molecular ciprofloxacin removal rates were an order of magnitude higher than
those for the ciprofloxacin-matrix. It is clear from comparing Figure 5.18a and b that pure
132

ciprofloxacin removal slowed dramatically in synthetic hospital effluent, unlike ciprofloxacin
matrix or TOC in the effluent. For pure ciprofloxacin and TOC, differences in removal rates by
persulfate level, observed in pure electrolyte, did not translate to differences in removal in effluent.
In fact, the ciprofloxacin removal rate from effluent with 3.1 mmol L-1 persulfate was actually
slower than with no persulfate. The only variable that was positively influenced by persulfate
addition to the effluent system was the ciprofloxacin-matrix, in which 80% and 88% faster removal
was obtained with the addition of 3.1 and 11 mmol L-1 persulfate, respectively. As with the FTR,
TOC rates between pure electrolyte and effluent only dropped between 21% and 43%, despite a
25 times increase in the initial amount of TOC. This confirms findings from the FTR that this
electrochemical process is capable of removing relatively high levels of organics from a complex
matrix such as hospital effluent.
Defluorination of ciprofloxacin in the effluent followed a similar linear trend to that in pure
electrolyte, although lower amounts of defluorination were achieved (Figure 5.19). There was also
a greater difference in the defluorination rate between 11 mmol L-1 persulfate and sulfate only
solutions when the effluent was present. This was correlated with the greater difference in
ciprofloxacin-matrix removal, where the ciprofloxacin-matrix was found in Chapter 4 to be
partially comprised of large fluorinated chromophores.
Persulfate behavior in the synthetic effluent was also evaluated, as shown in Figure 5.20.
While persulfate reduction was similar to that in pure electrolyte, persulfate generation from
sulfate was not observed. This matches findings in the FTR and further indicates an interfering
effect at the anode from the effluent.
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Figure 5.18. Ciprofloxacin degradation over time in pure electrolyte and synthetic hospital
effluent in a RDE reactor
Persulfate0 indicated on legend. Sulfate0 = 11 mmol L-1. TOC0=221 mg L-1 in effluent and 8.6 mg
L-1 in pure electrolyte. Ciprofloxacin0 = 0.043 mmol L-1. Current density 15 mA cm-2.
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Table 5.11. Reaction rate constants and statistics for RDE experiments in hospital effluent
Persulfate
(mmol L-1)

Pseudo-first
order
reaction rate constant
X 10-5 (s-1)

Ciprofloxacin in pure electrolyte
11
23.3
3.1
21.7
0
13.7
Ciprofloxacin in effluent
11
5.00
3.1
4.00
0
5.50

+/-

R2
for firstorder fit

% difference
from sulfate

Statistical significance of
difference from sulfate

6.5
6.5
1.8

.9251
.9742
.9622

41%
37%
n/a

p=0.0013
p=0.0039
n/a

1.0
0.67
1.8

.9134
.9308
.8446

-10%
-38%
n/a

p=0.6220 (not sig.)
p=0.0747
n/a

0.25
0.12
0.28

.9389
.9775
.2288

88%
80%
n/a

p < 0.0001
p < 0.0001
n/a

0.06
0.07
0.06

.9535
.9638
.9834

6%
6%
n/a

p=0.3127 (not sig.)
p=0.4917 (not sig.)
n/a

Ciprofloxacin-matrix in pure electrolyte: see Table 5.8
Ciprofloxacin-matrix in effluent
11
2.33
3.1
1.38
0
0.28
TOC in pure electrolyte: see Table 5.8
TOC in effluent
11
3.1
0

0.68
0.68
0.72
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Figure 5.19. Defluorination of ciprofloxacin in synthetic hospital effluent in a RDE reactor
Sulfate0 or Persulfate0 = 11 mmol L-1. Ciprofloxacin0 = 0.043 mmol L-1. Current density 15 mA
cm-2.
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Figure 5.20. Persulfate behavior during ciprofloxacin removal in synthetic hospital effluent
in a RDE reactor
(a) Persulfate concentration with time. (b) Modeling for Figure 5.20. (a-b) Persulfate0 indicated on
legend. Ciprofloxacin0 = 0.043 mmol L-1. Current density 15 mA cm-2. Persulfate generation from
sulfate did not occur and is not pictured.
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5.3.6 Inorganic disinfection by-products
The inorganic DBPs chlorite, chlorate, perchlorate and nitrite were evaluated to screen EAP for
practical application. This study was conducted on both the FTR and RDE reactor, and formation
amounts were compared between sulfate and persulfate electrolytes. The variable mg L-1 DBP
formed per mg L-1 TOC removed was utilized. Figure 5.21 shows that the formation of inorganic
DBPs in the FTR is mostly independent of the presence of persulfate. Slightly more chlorate was
formed in the FTR in the presence of persulfate.
Figure 5.22 shows that, like the FTR, formation of inorganic DBPs in the RDE is mostly
independent of the presence of persulfate.

Slightly more nitrite was formed in the RDE

experiments with persulfate than without persulfate.
While the persulfate independence shows that use of EAP does not provide additional
potential for inorganic DBP formation, the overall level of inorganic DBPS formed during the time
to achieve significant TOC removal is of concern for both electrochemical setups, as shown in
Table 5.12. The FTR generated over 200 mg L-1 perchlorate during the 60-minute effective
treatment time and the RDE generate over 29 mg L-1 perchlorate in a 24-hour treatment time.
Perchlorate is chemically stable because of its high activation energy (120 kJ mol-1) and is
not removed or destroyed by most traditional wastewater treatment processes224. With use of EAP
as a pre-treatment for release of hospital effluent to a WWTP, perchlorate may pass through the
system unchanged and enter the environment. The FTR-EAP system is not recommended in its
current design as a stand-alone treatment system. It may be best coupled with a successful
perchlorate removal technique, such as ion-exchange, which would serve to remove organic
components in the EAP phase and inorganic DBP through ion-exchange resin224.
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Figure 5.21. Formation of inorganic disinfection by-products in synthetic hospital effluent
in a FTR
Persulfate0 indicated on legend. Sulfate0 = 11 mmol L-1. TOC0=221 mg L-1. Current density = 6.9
mA cm-2 on FTR.
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Figure 5.22. Formation of inorganic disinfection by-products in synthetic hospital effluent
in a RDE reactor
Persulfate0 indicated on legend. Sulfate0 = 11 mmol L-1. TOC0=221 mg L-1. Current density = 15
mA cm-2.
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Table 5.12. Inorganic Disinfection By-product Formation During
Electrochemical Treatment of Ciprofloxacin
Disinfection
By-product
Nitrite

Chlorite

Chlorate

Perchlorate

Persulfate
(mmol L-1)
11
3.1
0
11
3.1
0
11
3.1
0
11
3.1
0

mg L-1
in RDE*
0.33
0.32
0.24
11.8
12.9
10.2
26.3
26.3
23.1
39.0
48.4
42.8

mg L-1
in FTR**
0.35
0.30
9.8
10.8
39.0
29.0
203.0
245.8

5.4 Conclusion
Overall, this study demonstrated successful electrochemical degradation of ciprofloxacin using
flow-through, batch and RDE reactors. Electrochemically activated persulfate demonstrated
improvement over sulfate in some cases in pure electrolyte, but showed limited benefit when
applied to a more complex matrix such as synthetic hospital effluent. Relative cathode size and
mass transfer effects were both suggested to influence the effectiveness of the systems, with at
least a 1:20 anode to cathode size ratio recommended to optimize contaminant removal. The
electrochemical systems showed efficacy for TOC removal even when TOC content was greatly
increased by addition of synthetic hospital effluent components; however, these systems also
generated high levels of perchlorate during TOC removal. Further work is recommended to study
multi-step treatment trains. Such systems might consist of electrochemical treatment with sulfate
or persulfate electrolyte, and a stage such as ion exchange to remove the generated inorganic DBPs.
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CHAPTER SIX: CONCLUSIONS
The research described in Chapters 3 and 4 provides fundamentals of electrochemical persulfate
activation, while Chapters 3, 4 and 5 examine application of EAP to ciprofloxacin degradation.
Throughout these studies, ciprofloxacin removal is analyzed in detail, while ciprofloxacin is also
used as a model compound to better understand EAP.
Chapters 3 and 4 assessed electrochemical persulfate activation without analyte in solution,
an important step to understand the fundamentals of EAP systems. In chapter 3, persulfate
activation by solid iron was proposed to be a surface dominated mechanism. The relationships
between iron surface area, applied current, iron production and persulfate activation were
elucidated. Sustained persulfate activation was accomplished with the use of solid iron, with 1.14
moles of persulfate activated for 1 mole of iron used. It was found that the surface area of the solid
iron could be adjusted to control the persulfate activation rate. Applied current enhanced persulfate
activation until diffusion limitations were reached. In Chapter 4, anodic sulfate radical formation,
anodic non-radical persulfate activation and cathodic persulfate activation were discovered to be
persulfate activation mechanisms. Cathodic activation was found to be the same for graphite and
platinum materials. Persulfate generation from sulfate at a BDD anode was also confirmed. Net
persulfate activation increased linearly with increased current density, within the range tested.
Chapters 3, 4 and 5 examined parameters affecting ciprofloxacin removal using EAP. In
Chapter 3, EAP using an iron anode and graphite cathode was evaluated without current and at
three levels of applied current. Although applied current did not enhance ciprofloxacin removal,
significant defluorination and ciprofloxacin-matrix removal was attained from the chemical
activation of persulafte by the solid iron rod. Sustained persulfate activation and minimal iron
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usage was achieved. In Chapter 4, ciprofloxacin degradation was accomplished with applied
current using a BDD/Gr anode/cathode pair without the addition of iron.

Significant

improvements in removal rates were achieved by using sulfate instead of nitrate electrolyte, and
even more benefit was gained through the use of persulfate electrolyte, in other words, EAP.
Pathways of ciprofloxacin transformation were elucidated.

Chapter 5 evaluated effects of

persulfate concentration, anode:cathode size ratio, and reactor configuration. It was found that at
least a 1:20 anode:cathode size ratio was needed to benefit from EAP. In the flow-through reator
configuration, increasing persulfate concentration only offered moderate improvements for
ciprofloxacin removal, likely due to mass-transfer limitations and the sub-optimal anode:cathode
size ratio used. EAP was slightly more effective in a batch reactor. The RDE reactor provided the
most effective use of activated persulfate with increasing removal rates seen as persulfate
concentration was increased. This was attributed to the larger relative cathode size (at least 1:20
anode:cathode was found to be optimal) and minimization of mass-transfer limitations.
Chapter 5 evaluted the use of EAP for ciprofloxacin removal from synthetic hospital
effluent. Removal slowed down significantly in the effluent solution versus using pure electrolyte.
There were no differences in removal of ciprofloxacin or TOC when using EAP or sulfate
electrolyte for effluent treatment in the FTR. Overall, the system was successful in removing high
amounts of TOC from the effluent. On the RDE, EAP increased removal rates of the ciprofloxacinmatrix but did not increase the removal of the ciprofloxacin itself or TOC. Again, high levels of
TOC removal from the effluent was achieved. During ciprofloxacin treatment in effluent in the
FTR and RDE reactors, high levels of disinfection by-products were formed. It was recommended
that future studies incude pairing EAP with another treatment step, such as ion exchange, to
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remove combine TOC removal with DBP removal. It is also recommended to assess EAP with
other organic analytes, where enhancements seen with ciprofloxacin in the pure electrolyte on the
RDE may better translate to a flow-through reactor design in a complex matrix.
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Table A1. Iron, Heat and Ultraviolet Light Activated Persulfate Degradation of Various Organics
Iron-Activated
Degradation

Analyte
(mmol L-1)

Aniline100
0.05
Aniline106
0.05
Bisphenol A99
80
Bisphenol A99
80
Bisphenol A99
80
-Nitroaniline109
0.2
2,4-Dichlorophenol121
0.184
Orange G225
0.1
Trichloroethene225
0.1
167
Trichloroethene
0.15
Trichloroethane173
0.15
Heat-Activated Degradation

2.5
2.5
2
2
2
8
12
1
1
4.5
2.25

Maximum
Analyte
Removal
100%
73%
100%
100%
97%
100%
93%
100%
100%
>99%
>99%

Aniline100
Atrazine148
2,4-Dichlorophenol121
Dimethyl Phthalate116
1,4-Dioxane49
1,4-Dioxane49
Monochlorobenzene226

2.5
1
12
10.8
26
26
179

100%
100%
100%
100%
100%
100%
100%

0.05
0.05
0.184
0.0515
1.135
1.136
0.00179

Persulfate
(mmol L-1)

Rxn
Time
(min)
10
240
45
30
30
270
60
30
120
5
30

Optimal Molar Ratio

Form of Iron

1:50:100
1:125:25
1:5:4
1:5:4
1:5:4
1:40:115
1:65:197
1:10:10
1:10:10
1:30:30:150
1:15:2:10
Optimal Temp. (C)

Fe0
Fe2+
Fe0
Fe2+ Continuous addition
Fe2+ Sequential addition
nano-Fe3O4
nano-Fe0
Fe2+ or Fe3+
Fe0
Fe0, biochar support
Fe2+, hydroxylamine
Synergistic Effects

60
90
60
1080
180
240
120

80
60
50
40
60
60
60

+5mM Fe0
none
+36mM Fe0
none
none
+18mM Fe2+
none

Fluence Rate (mW cm-2)

Synergistic Effects

1.29
0.18

no pH effect

Wavelength/Power
(nm/W)
254 / 14

pH=7.4
no pH effect
+0.2 g/L Fe3O4

254 / 254 / 60
295-400 / 20

UV Light-Activated Degradation
Acid Blue 113126
227

Atrazine
2-Methylisoborneol160
Phenol129

0.073

6.3

97.70%

120

0.00464
0.238
0.1

1
0.01
0.5

50%
86%
95%

10
900
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Table A2. Degradation of BTEX and Phenols by Iron-Activated Persulfate
Analyte

Analyte
(mmol L-1)

Persulfate
(mmol L-1)

*Form of
Iron

**Optimal Molar
Ratio

Maximum
Analyte
Removal

Rxn
Time
(min)

Benzene 228

1

20

Chelated (Citric Acid) Fe2+

1:20:5:5

100%

70

1

100

Fe2+

1:100:4

60%

5

1

100

Fe2+

1:100:5

63%

5

2+

1:27:08

84%

60

Ethylbenzene228
229

1

27.3

Fe

Toluene228
Xylene228

1

100

Fe2+

1:100:5

50%

5

1

100

Fe

2+

1:100:5

60%

5

4-Chlorophenol153

0.156

0.78

Fe0

Toluene

p-Nitrophenol

61

1:5:23

88%

60

2+

1:5:20

31%

240

0.156

0.78

Fe

0.156

0.78

Fe3+

1:5:20

17%

240

2+

1:42:42

20%

180

1:42:42

15%

180

0.72

30

Fe

0.72

30

Cu2+

*granular batch addition unless otherwise noted **Molar Ratio of Organic: Persulfate: Fe or Organic: Persulfate: Fe:Other Component
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Table A3. Degradation of Various Organics by Iron-Activated Persulfate
Analyte

Analyte
Conc.
(mmol L-1)

Chlorobenzene98

Cyclohexanoic acid120
2,4-Dinitrotoluene

Methyl
Ether98

79

*Form of
Iron

**Optimal
Molar Ratio

Maximum
Analyte
Removal

Rxn
Time
(min)

2.665

53

nano-Fe0

1:20:20

97%

1200

2.665

53

Fe2+

1:20:20

97%

1200

1:20:20

71%

1200

1:266:4590

82%

8640

1:5:623

100%

120

0

2.665

53

Fe

0.039

10.4

nano-Fe0
0

0.275

1.3

Fe

0.275

1.3

Fe2+

1:5:623

22%

240

3.523

70.5

nano-Fe0

1:20:20

40%

960

3.523

70.5

Fe2+

1:20:20

28%

960

1:20:20

28%

960

1:538:231

>99%

7

1:20:20

>99%

1080

1:20:20

>99%

1140

1:20:20

>99%

1200

1:2:2

100%

240

1:2:2

70%

240

tert-Butyl

Napthalene179
Napthalene

Persulfate
Conc.
(mmol L-1)

98

Polyvinyl Alcohol92

Trichloroethene98

0

3.523

70.5

Fe

0.078

42

Fe0, sequential addition

0.101

2.02

nano-Fe

0.101

2.02

Fe2+

0

0

0.101

2.02

Fe

0.581

1.3

Fe2+
0

0.581

1.3

Fe

2.854

57

nano-Fe0

1:20:20

94%

1440

2.854

57

Fe0

1:20:20

80%

1440

2.854

57

Fe2+

1:20:20

78%

1440
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Table A4. Degradation of Pharmaceuticals by Iron-Activated Persulfate
Analyte

Analyte
(mmol L-1)

Persulfate
(mmol L-1)

*Form of
Iron

**Optimal
Molar Ratio

Maximum
Analyte
Removal

Rxn
Time
(min)

Acetaminophen230

0.060

4.8

Fe0

1:80:80

60%

240

Caffeine

97

2+

Carbemazepine149

0.0258
0.0258
0.150
0.150
0.050

7.36
7.36
6
6
0.2

Fe Continuous addition
Fe2+
Fe2+, Cl- addition
Fe2+
Fe2+

1:285:285
1:285:285
1:40:5
1:40:5
1:4:2

100%
90%
100%
50%
30%

15
15
10
40
60

Ciprofloxacin96

0.030

2.4

1:80:80

96%

30

0.030

0.3

Fe2+
Fe2+ or Chelated (Citric Acid)
Fe2+

1:10:10:10

70%

30

0.0236

7.36

Fe2+ or Fe2+ Continuous addition

1:312:312

100%

15

1:238:238

100%

15

1:264:264

100%

30

1:264:264

47%

30

Ibuprofen97
Nicotine

97

0.0309
97

Phenacetin

0.0279
0.0279
144

Sulfadiazine
Sulfamethoxazole95

230

7.36
7.36
7.36

2+

2+

Fe or Fe Continuous addition
2+

Fe Continuous addition
Fe

2+

0

0.008
0.039
0.039
0.039
0.039
0.030

1.8
1.0
1.0
1.0
1.0
2.4

Fe
Fe0
CoAgFe
CoFe, AgFe, AgCoFe
Fe2+ Sequential addition
Fe2+

1:225:225
1:25:56
1:25:56
1:25:56
1:25:56
1:80:80

46%
95%
95%
95%
80%
75%

60
20
30
50
120
30

0.036

2.9

Fe0

1:80:80

60%

5

1:10:10:10
1:25:56

50%
40%

30
120

2+

0.030
0.039

0.3
1.0

Chelated (EDTA) Fe
Fe2+

0.030

0.3

Chelated (Citric Acid) Fe2+

1:10:10:10

35%

30

0.030

0.3

Fe2+

1:10:10

30%

30

0

Triclosan
0.031
2.5
Fe
1:80:80
60%
*granular batch addition unless otherwise noted **Molar Ratio of Organic: Persulfate: Fe or Organic: Persulfate: Fe:Other Component
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5

Table A5. Degradation of Phenyls and Dyes by Iron-Activated Persulfate
Analyte

Aniline106
Aniline

155

Aniline

106

Diuron94
94

Diuron

Diuron

Analyte
(mmol L-1)
0.050
0.10

Persulfate
(mmol L-1)

*Form of
Iron

**Optimal
Molar Ratio

Maximum
Analyte
Removal

Rxn
Time
(min)

2.5

Chelated (Citric Acid) Fe2+

1:50:25:25

60%

240

1:25:0.5

55%

10

1:50:25:25

50%

240

1:50:25

45%

240

1:50:25:25

45%

240

2.5

Fe

2+

0.050

2.5

Chelated (EDTA) Fe

0.050

2.5

Fe2+

2+

2+

0.050

2.5

Chelated (Oxalic) Fe

0.0215

7.36

Fe2+ Continuous addition

0.0858

3.1

1:340:340

100%

15

2+

1:36:36

100%

30

2+

1:36:36

100%

30

1:340:340

90%

15

1:20:20

90%

240

Fe Continuous addition

0.0858

3.1

Fe

0.0215

7.36

Fe2+

231

2+

Diuron

0.010

0.2

Chelated (Citric Acid) Fe

PCB28108

0.025

2

nano-Fe3O4, air purge

1:80:720

100%

200

0.025

2

nano-Fe3O4-Fe2+

1:80:720

95%

120

0.025

2

nano-Fe3O4

1:80:720

90%

240

p-Chloroaniline232

0.050

2.5

Fe0

1:50:1700

100%

12

Reactive Blue 1980
Congo Red178

0.1
0.287

10
0.4

Fe0
Zerovalent zinc

1:100:143
20mM

100%
60%

45
180

*granular batch addition unless otherwise noted **Molar Ratio of Organic: Persulfate: Fe or Organic: Persulfate: Fe:OtherComponent

166

Table A6. Degradation of Ethenes, Phenols and Phenyls by Thermally Activated Persulfate
Analyte

Analyte
(mmol L-1)

Persulfate
(mmol L-1)

Heating
Method

Optimal
Temp.
(C)

Synergistic
Effects

Reaction
pH

Maximum
Analyte
Removal

Rxn
Time
(min)

Reaction Rate
Constant (min1
)

Aniline154

0.030

100

conventional

50

none

7

75%

180

-

Diuron94, 233

0.0858

3.1

conventional

50

+0.90
Fe2+

mM

3-9

100%

30

-

0.09

2.1

conventional

50

+0.72
Fe2+

mM

2.5

100%

180

0.00451

0.050

2.5

conventional

50

+12.5
Fe0

mM

7

85%

300

-

0.050

2.5

conventional

50

none

7

58%

300

-

0.0375

0.75

microwave

90

none

-

100%

40

0.1526

0.0375

0.75

conventional

90

none

-

94%

40

0.0707

0.0375

0.112

microwave

130

none

-

90%

1

rapid

p-Nitroaniline109

0.200

8

conventional

55

+23mM
nano-Fe3O4

7

98%

20

0.19

p-Nitrophenol61

0.720

30

conventional

70

-

100%

180

0.0276

0.720

30

conventional

90

Fe2+,Cu2+ did
not increase
degradation

-

100%

20

0.2942

0.045

0.45

conventional

60

none

-

94%

60

0.0332

0.150

300

conventional

50

none

-

100%

9

-

p-Chloroaniline232

Pentachlorophenol

11

5

Tetrachloroethene63
Trichloroethene

234
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Table A7. Degradation of Pharmaceuticals by Thermally Activated Persulfate
Analyte

Analyte
(mmol L-1)

Persulfate
(mmol L-1)

Heating Method

Optimal
Temp.
(C)

Synergistic
Effects

Reaction
pH

Antipyrine114

0.0265

1.855

conventional

70

none

7.1

94.0%

40

0.0854

0.0265

2.65

conventional

60

none

4

71.4%

120

0.0092

0.200

4

conventional

80

none

5.4

>99%

40

0.0593

0.200

4

conventional

50

none

5.4

31%

160

0.0024

0.047

0.47

Conventional

70

None

7

>90%

120

0.0162

0.0204

1

conventional

70

none

7

100%

20

0.183

0.0204

1

conventional

60

none

4

85%

60

0.0161

0.050

2.5

conventional

90

none

4.7

80%

60

0.0271

0.050
0.050

2.5
2.5

microwave
microwave

90
130

none
none

4.7
4.7

100%
100%

16
1

0.291
rapid

Chloramphenicol
Diclofenac

235

172

165

Ibuprofen

Sulfamethoxazole

118

168

Maximum
Analyte
Removal

Rxn
Time
(min)

Reaction Rate
Constant
(min-1)

Table A8. Degradation of Various Organics by Thermally Activated Persulfate
Analyte

Analyte
(mmol L-1 )

Persulfate
(mmol L-1 )

Heating
Method

Optimal
Temp.
(C)

Synergistic
Effects

Maximum
Analyte
Removal

Rxn
Time
(min)

Reaction Rate
Constant
(min-1)

Cyclohexanoic acid120

0.039

10.4

microwave

80

Fe0 did not
increase
degradation

100%

120

-

conventional

40

none

100%

1080

0.00172

Dimethyl Phthalate116
Methyl tert-Butyl Ether
Perfluorooctanoic Acid
81, 92, 93, 236-238

Polyvinyl Alcohol92

Landfill Leachate163

Spent Caustic239

0.0515
57

10.8

0.060

31.5

conventional

50

none

100%

150

0.0348

0.2415
0.254
0.254
0.254
0.254

200
50
10
5
5

conventional
microwave
microwave
microwave
microwave

40
90
90
90
90

none
none
none
+3.6 mM Fe0
none

100%
99.3%
77%
67.60%
62.60%

4320
240
120
120
240

0.00086
0.01633
0.00122
0.0417
0.0008

0.0005

10

conventional

85

none

93.50%

3060

0.00158

0.581

1.00

conventional

80

100%

10

0.4238

0.581

1.00

conventional

60

Fe2+,Fe0 did not
increase
degradation
Fe2+,Fe0 did not
increase
degradation

100%

30

0.0846

2090mg/L
TOC

22

microwave

85

none

79.4

30

0.0099

80

Fe2+,Fe0 did not
increase
degradation
+9mM Fe0

95%

120

0.0134

2090mg/L
TOC

45

conventional
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Table A9. Degradation of Pharmaceuticals by Ultraviolet Light Activated Persulfate
Analyte

Analyte
(mmol L-1)

Persulfate
(mmol L-1)

UV
Wavelength/Power
(nm/W)

Fluence
Rate
(mW/cm2)

Ciprofloxacin185
Acetaminophen158
Ampicillin53

0.0302
0.017
0.050

8
0.132
1

1
0.114
0.1

Carbemazepine128
Cephalothin53

0.050
0.050
0.050

0.2
0.2
1

Florfenicol161
Sulfadiazine240
Sulfamethizole240
Sulfamethoxazole240
Sulfathiazole240
Tylosin150

0.02
0.080
0.074
0.079
0.078
0.0055

2
0.5
0.5
0.5
0.5
2

254 / 8
253.7 / 75
254 / 50
(two lamps)
290 max / 1800
290 max / 1800
254 / 50
(two lamps)
254 / 254 / 8
254 / 8
254 / 8
254 / 8
- / 30W

Maximum
Analyte
Removal

Rxn
Time
(min)

Reaction
Constant
(min-1)

-

95%
100%
75%

30
60

0.2988
0.0453

0.1

+0.1mMol/L Fe2+
-

100%
60%
91%

30
60

0.109
0.0051

0.112
0.112
0.112
0.112
-

+93uM nano-Ag

100%
93%
97%
98%
99%
90.90%

60
180
180
180
180
35

0.0325
0.0245
0.0096
0.0283
0.0141
-

170

Synergistic
Effects

Rate

Table A10. Degradation of Various Organics by Ultraviolet Light Activated Persulfate
Analyte

Analyte
\(mmol L-1)

Persulfate
(mmol L-1)

Fluence
Rate
(mW cm-2)

Synergistic
Effects

Maximum
Analyte
Removal

Rxn
Time
(min)

20

UV
Wavelength/
Power
(nm / W)
254 / -

2,2,3,3-tetrafluoro-1propanol82

1.390

Acid Red 14241

2.04

pH=3.0

100%

60

0.040

5.0

200-280 / 30

-

75%

15

Anthracene242

0.004

0.08

300 / -

-

Nano-TiO2 on
glass beads
-

90%

6

0.35

Geosmin160

0.219

0.01

254 / 60

1.29

no pH effect

94.50%

10

7.6*108
L(mol-s)-1

Imazalil243

0.084

42.2

365 / 125

31

pH=6.5

100%

120

0.596

0.084

21.1

365 / 125

31

100%

240

0.501

0.050

1

254 / 50

0.1

pH=3.0; +2.5
g/L TiO2
pH=2.0

0.0148

1.1

220-460 / 200

-

0.48 MPa O2

100%

720

-

Perfluorooctanoic Acid

0.0296

1.1

220-460 / 200

-

0.48 MPa O2

100%

240

-

Phenol129

0.100

Nitrobenzene53
Perfluorononanoic Acid

Polyvinyl Alcohol

244

125, 245

Tetrabromobisphenol A

-

50

295-400 / 20

0.18

-

95%

300

-

-1

0.325

254 / 8

-

pH=3.0

100%

<5 min

1.5509

-1

0.5

254 / 8

-

-

100%

<5 min

2.3438

-1

20 mg L

0.5

365 / 8

-

-

93%

30

0.0275

0.100

20

365 max / 100

-

pH=13.0

99%

180

-

20 mg L
20 mg L

127

75%

Reaction
Rate
Constant
(min-1)
-
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Table A11. Degradation of Various Organics by Electrochemically Activated Persulfate
Analyte

Acid Orange 7246

Aniline50
Bisphenol A143

Analyte
(mmol L-1)

Persulfate
(mmol L-1)

Anode

Cathode

Synergistic Effects

Electrical
Properties

pH

0.1

12

16.8 mA cm-2

12

none

64

3% by wt.

stainless
steel
stainless
steel
Pt

1 mM Fe2+

0.1

Ti/RuO2/Ir
O2
Ti/RuO2/Ir
O2
Pt

220

10

Ti/RuO2/Ir
O2

1% by wt.

Reaction
duration
(min)
60

16.8 mA cm-2

3

65.8%

60

150mL/min N2

6V

3.7

100%

420

stainless
steel

2mM Fe3+

16.8 mA cm-2

3

>99%

120

Pt

Pt

150mL/min N2

6V

0.5

98%

480

stainless
steel
stainless
steel
stainless
steel
Fe

1g/L Fe-Co/SBA15 catalyst
1g/L Fe-Co/SBA15 catalyst
none

16.8 mA cm-2

6

95.6%

60

8.4 mA
cm-2
8.4 mA cm2

6

90.5%

60

6

89.4%

60

Fe from electrodes

90 mA cm2

4.5

38%

20

Mixed
Metal
Oxide
Ti

up to 1.8mM Fe
from Fe anode

100 mA

5.6

100%

90

15.6 mM Fe2+

13.9 mA cm-2

3

62.2%

60

Dinitrotoluene59

25 mg
TOC

Orange II169

100 mg L-1

8.4

100 mg L-1

8.4

100mg/L

8.4

50

0.115

Ti/RuO2/Ir
O2
Ti/RuO2/Ir
O2
Ti/RuO2/Ir
O2
Fe

400

5

Fe

62.5

Ti/IrO2RuO2-TiO2

Pentachlorophenol14

L-1

3

Max
Analyte
Removal
95.7%

2

Trichloroethene141
Landfill leachate164

1900 mg L-1
COD
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Table A12. Degradation of Various Organics Using Unique Methods of Persulfate Activation
Analyte

Analyte
Conc.
(mmol L-1)

Persulfate
Conc.
(mmol L-1)

Activator

Activator Properties

Maximum
Analyte
Removal

Optimization

Reaction
Constant
(min-1)

Benzotriazole86

0.02

0.5

Weak magnetic
field with Fe0

+0.5mM Fe0; pH=7.0

>90%

WMF resulted in
increase in removal

0.0126

Caffeine86

0.02

0.5

Same as above

Same as above

100%

Same as above

0.0175

Diuron86

0.02

0.5

Same as above

Same as above

100%

Same as above

0.0291

4-nitrophenol86

0.02

0.5

Same as above

Same as above

>95%

Same as above

0.0189

Ammonia
Perfluorooctanoate56

0.0464

10

Ultrasonication

300W, 20kHz

51.20%

1.3

Ultrasonication
plus Fe0

60W; +2.1mM Fe0;

96.40%

Ultrasonication
Heat, UV , Fe2+
or
Utrasonication

90 Watts; +0.2mM Fe0
UV=254nm,15W;
US=2W/cm2
,40kHz;
Fe2=3mM

99.10%
22.5% with
temp

pH = 3.0

gamma
irradiation

80 kGy dose

97%

Addition
persulfate
less dose

0.1mM

88%

pH = 7.4

0.2g/L catalyst

100%

Acid Orange 758
Sulfadiazine144

0.008

1.84

Perfluorooctanoicsulphonic Acid247

0.0185

18.5

Ibuprofen60

1

20

PCB2851

0.002

5

Phenol68

0.213

6.2

p-Hydroxybenzoic
Acid66

0.1

2

electron beam

3MeV vertical scan
beam; 600 Gy dose

80%

Acid Orange 7146

0.057

5.7

activated carbon

5g/L (adsorbent
catalyst)

and

>97%

Perfluorooctanoic
Acid67

0.1206

6.3

activated carbon

10g/L (adsorbent
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Figure A1. Mass spectra for byproducts are shown for a-h) nitrate, i) sulfate, and j-u) persulfate at
various time points during the degradation of ciprofloxacin.

174

Figure A1. Continued

175

Figure A1. Continued

176

Figure A1. Continued

177

Figure A1. Continued

178

Figure A1. Continued

179

Figure A1. Continued

180

Figure A1. Continued

181

Figure A1. Continued

182

Figure A1. Continued

183

Figure A1. Continued

184

Figure A1. Continued

185

VITA
Laura Matzek was born in Knoxville, TN. She graduated from the University of Tennessee,
Knoxville in 1998 with a Bachelor’s of Science in Chemical Engineering. After graduation, she
worked as an engineer for the DuPont Corporation in Chattanooga, TN for three years and for
Intraspec, Inc in Oak Ridge, TN for five years. She was an instructor at Roane State Community
College and Chattanooga State Community College before attending graduate school. Ms. Matzek
will receive her doctorate in environmental engineering in May 2018. She currently lives in Lenoir
City, TN with her husband and two children.

186

